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	Abstract 
 
Polycomb protein RING1B is part of the E3 ligase that makes the core component of 
Polycomb Repressive Complex 1 complexes responsible for monoubiquitination of histone 
H2A at lysine 119. RING1B has been described as transcriptional repressor and chromatin 
modifier, indispensable for a proper embryonic development and lineage specification in 
cellular differentiation. Previous work in our laboratory has revealed additional, non 
transcriptional functions for RING1B i.e in S-phase progression.   
Using unperturbed neural stem cells (NSCs) derived from a murine conditional model of 
loss-of-function of RING1B, we unveil roles of RING1B in cell proliferation, DNA damage 
and redox homeostasis, independently of its activity as transcriptional repressor. RING1B 
deficiency caused p21/CDKN1A upregulation, the principal mediator of the proliferative 
defect. This is mostly due to activation of DNA damage response (DDR). Upregulation of 
p21 followed the known ATM/P53/p21 DDR axis, as shown by restoration of proliferation 
rate in p21/Cdkn1a and Tp53 knock out NSCs, or in the presence of ATM inhibitor. 
Concurrent with proliferation arrest of RING1B-depleted NSCs, accumulation of double-
strand breaks (DSBs) originated, at least in part, by an increase in endogenous Reactive 
Oxygen Species (ROS). Consistently, treatment with antioxidant was able to decrease DNA 
damage and recover normal proliferation. This essential function, preventing accumulation 
of ROS in NSCs was fulfilled by RING1B, but not its paralog RING1A through stabilization 
of Polycomb cofactor BMI-1.  
In summary, we have identified a novel function of RING1B promoting proliferation of 
multipotent progenitors through the maintenance of physiological levels of oxidative stress, 
avoiding and managing a response to DNA damage through mechanisms independent, at 
least partially, of its better known as transcriptional repressor and instead assuring the 
stability of its own cofactor in NSCs.  
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Resumen 
 
La proteína RING1B es el componente principal del Complejo Represor Polycomb 1 
(Polycomb Repressive Complex , PRC1) y cataliza la monoubiquitinación de la lisina 119 de 
la histona H2A. RING1B se ha descrito como un represor transcripcional y modificador de 
la cromatina y se conoce para su papel clave en el correcto desarrollo del embrión y 
especificación celular en la diferenciación celular. Recientemente, en nuestro laboratorio se 
han descrito para RING1B funciones adicionales a las transcripcionales, tales como la 
correcta progresión por la fase S del ciclo celular.  
En este trabajo hemos utilizado como modelo experimental células madre neurales crecidas 
en condiciones de proliferación, y hemos podido desvelar la participación de RING1B en la 
proliferación celular, daño al DNA y control de la homeostasis oxidativa. La deficiencia de 
RING1B causa una mayor expresión del inhibidor del ciclo celular p21/CDKN1A que ha 
resultado ser el principal mediador de la parada proliferativa. La expresión de 
p21/CDKN1A es consecuencia de la activación de una respuesta a daño al DNA y no 
simplemente de la ausencia de una represión transcripcional. En la respuesta a daño a DNA 
participan la quinasa ATM y la proteína P53, como demuestra la recuperación de la 
proliferación en ausencia de p21/Cdkn1a o Tp53, y también por tratamiento con un inhibidor 
de la actividad quinasa de ATM. En este trabajo se ha demostrado como RING1B es 
importante para prevenir la formación de rupturas dobles de cadena del DNA que se 
originan, principalmente, por el incremento de Especies Reactivas del Oxigeno ("Reactive 
Oxygen Species", ROS) en las células mutantes, y que finalmente llevan a una parada de la 
proliferación. En consonancia, el tratamiento con el antioxidante N-acetil-cisteína previene la 
formación de daño a DNA y permite rescatar la proliferación. Los datos aquí presentados 
sugieren que el papel de RING1B, y no de RING1A, se desarrolla garantizando la 
estabilidad de su co-factor BMI-1, ya descrito como  regulador de la homeostasis oxidativa.  
En conjunto, en este trabajo se han identificado nuevas funciones de RING1B en prevenir el 
estrés oxidativo y la consecuente activación de una respuesta de daño al ADN de manera 
independiente de su función como represor transcripcional, y que implica la estabilización de 
su co-factor BMI-1 en células madre neurales. 
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4’-OHT: 4’-hydroxytamoxifen 
53BP1: p53-binding protein 1 
8-oxoG: 8-oxo-guanine 
ATM: ataxia telangiectasia mutated 
ATMi: ATM inhibitor 
ATR: ataxia telangiectasia and Rad3-related protein 
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CDK: cyclin-dependent kinase 
CDKI: cyclin-dependent kinase inhibitor  
cDNA: complementary DNA 
ChIP: chromatin immunoprecipitation 
CHK1: serine/threonine-protein kinase 1 
CHK2: serine/threonine-protein kinase 2 
CreERT2: Cre recombinase - estrogen receptor T2 
Ct: cycle threshold 
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DDR: DNA damage response 
Dox: doxycycline 
DSBs: double-strand breaks 
d.p.c.: days post coitum 
EdU: 5-ethynyl-2’-deoxyuridine 
EED: embryonic ectoderm development 
EtOH: ethanol 
EZH: Enhancer of zeste homolog  
FITC: Fluorescein isothiocyanate 
H2AK119Ub: mono-ubiquitylated lysine 119 of histone H2A 
H2AX: Variant X of histone H2A 
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H2Aub: mono-ubiquitylated histone H2A 
H3K27me3: trimethylated lysine 27 of histone H3 
HBSS: Hank's buffered salt solution 
HCl: hydrochloric acid 
HR: homologous recombination 
IF: immunofluorescence 
IP: immunoprecipitation 
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lncRNA: long non-coding RNA 
mEFs: murine embryonic fibroblasts  
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p16-INK4a: cyclin-dependent kinase inhibitor 2a 
p21/CDKN1A: cyclin-dependent kinase inhibitor 1a 
p27/CDKN1B; cyclin-dependent kinase inhibitor 1b 
p57/CDKN1C; cyclin-dependent kinase inhibitor 1c 
RGC: radial glial cell 
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RYBP: RING1 and YY1-binding protein 
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SD: standard deviation 
SDS: Sodium dodecyl sulfate 
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ssDNA: single-stranded DNA 
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1. Polycomb system of chromatin regulators 
 
The PcG of genes were discovered during the genetic analysis of development in the fly 
Drosophila melanogaster (Lewis, 1978; Duncan, 1982). Phenotypically, adults bearing 
Polycomb mutations shared morphological alterations interpreted as homeotic 
transformations, i.e. when a body part acquired structures from another body part. 
Generally, in PcG alterations, anterior body structures acquire features of a posterior part. 
Thus, in male flies, the presence of sex combs, a structure usually restricted to the last pair 
of legs, in the first and second pairs, as if these anterior legs became more like the posterior 
leg. It is, precisely, the presence of supplemental sex combs what determined the branding 
of the collection of mutations: the Polycomb group of genes, the founder member after the 
Polycomb (Pc) mutant. Other mutations were Posterior sex combs (Psc), Sex combs extra 
(Sce), Additional sex combs (Asx). 
 
These mutations resembled those associated to the gain of function of the homeotic genes 
and thus, PcG genes were considered negative regulators of Hox genes. Characteristically, 
Polycomb larvae show expanded expression domains of Hox products, in contrast with the 
restricted patterns seen in wild type larvae (Lewis, 1978; Duncan, 1982; T. Sato & Denell, 
1985; Schwartz & Pirrotta, 2007). This feature is consistent with a loss of gene silencing 
function and thus the association of PcG products with transcriptional repression (Isono et 
al., 2005). 
 
Following the molecular cloning of Drosophila PcG genes, the conservation of their 
products was soon appreciated in mammalian cells (Aranda et al., 2015; Whitcomb et al.,  
2007). Given the notion that Polycomb products might act as protein complexes (supported 
by the phenotypic similarity of Polycomb mutations) a characterization of components of 
these complexes was initiated that led to the identification, among others, of RING1 
proteins. Interestingly, no Drosophila Polycomb gene was known at the time that encoded a 
RING1 homolog. However, soon after molecular and genetic studies found that Drosophila 
Sex combs extra encoded a RING1 protein homolog. It was the case of a Polycomb gene 
identified in mammalian before than in Drosophila model (Fritsch et al., 2003; Gorfinkiel et 
al., 2004). 
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1.1. Polycomb Repressive Complexes (PRC) 
 
1.1.1. PRC1 and PRC2 complexes 
 
PcG proteins in both fly and mammalian cells are found as two major types of biochemical 
entities known as Polycomb Repressive Complexes 1 and 2 (PRC1, PRC2). PRC1 and 
PRC2 interact and modify chromatin in different ways. These sets of complexes include a 
heterogeneous mix of assemblies, particularly that of PRC1 complexes (Aranda et al., 2015; 
Gao et al., 2012; Lanzuolo & Orlando, 2012).  
 
PRC1 complexes contain a core composed by RING1 proteins (RING1A/B) that display 
E3 ligase activity monoubiquitinating histone H2A at lysine 119 (K119Ub, H2AUb in 
short). (Cao, Tsukada, & Zhang, 2005). Loss of these PRC1 components RING1A and 
RING1B results in a drastic reduction in basal levels of H2Aub (de Napoles et al., 2004), 
thereby demonstrating the exclusive requirement for these enzymes in catalyzing this 
particular modification. Core PRC1 complex also contains one of the six PCGF proteins 
defining the PRC1 complex (Gao et al., 2012). PRC1 complexes composed by 
PCGF2/MEL18 or PCGF4/BMI-1 are named PRC1.2 and PRC1.4, respectively, and are 
considered as ‘’canonical PRC1’’ because they include, together with one Polyhomeotic 
subunit (PHC1, 2 or 3), a Chromobox (CBX2, 4, 6, 7 or 8) subunit. CBXs proteins have a 
chromodomain at the N-terminal that recognize histone mark deposited by PRC2 
(Bernstein et al., 2006; Fischle et al., 2003). Non-canonical PRC1 complexes do not contain 
a CBX protein, but include instead RYBP or its homologue YAF1, that bind to core 
RING1-PCGF on its own or complexed with diverse subunits combinations (Gao et al., 
2012; Tavares et al., 2012).  
 
PRC2 complexes are composed by a methyltransferase called Enhancer of Zeste 1 or 2  
(EZH1 or EZH2), that catalyzes the mono, di or tri-methylation of lysine 27 on histone H3 
(H3K27me3), SUV12 and EED proteins (Margueron et al., 2008 and 2011; Shen et al., 
2008). 
 
PRC1 and PRC2 interact and mutually reinforce their activities. Specific recognition of the 
histone modifications is the basis of the interdependent relationship between PRC1 and 
PRC2. As already mentioned, not only PRC1 CBX subunits recognize PRC2 methylated 
histone mark (Bernstein et al., 2006; Fischle et al., 2003) but also, PRC2 recognition of 
nucleosomes bearing H2AUb stimulates the lysine methyltransferase activity of EZH 
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proteins. It is important to note that PRC1 and PRC2 also associate and modify chromatin 
independently of each other (Blackledge et al., 2014; Kalb et al., 2014). 
 
1.1.2. Recruitment mechanisms 
 
How Polycomb complexes are recruited to their targets and the mechanisms through which 
Polycomb-modified chromatin is functionally altered are currently subject of intense 
research activity. Studies in Drosophila melanogaster determined the existence of hundreds-
bases sequences able to recruit Polycomb proteins, called PRE (Polycomb Response 
Elements) (Chan et al., 1994; Mihaly et al., 1998; Tillib et al., 1999). These regions could 
localize kilobases far from target promoter or, in same cases, close to TTS (transcription 
starting site). In mammalians cells, there are no PRE elements on the genome, but PRC1 
and PRC2 proteins have high affinity for CpG islands (un-methylated regions rich in 
cytosine and guanine bases) that could function as PRE elements in mammalian cells 
(Boyer et al., 2006; Ku et al., 2008; T. I. Lee et al., 2006; Mikkelsen et al., 2007).  The 
recruitment of Polycomb proteins to CpG island is mediated by a DNA binding protein, 
KDM2B, that is part of the PRC1.1 (non-canonical) complex, through a ZF-CxxC binding 
domain with high affinity to CpG islands (Farcas et al., 2012; He et al., 2013; Wu et al., 
2013). These observations suggest a more general recruitment model, called ‘’sampling’’ 
where PRC1 and PRC2 or Trithorax group of proteins (antagonist of Polycomb’s) 
(Ringrose & Paro, 2004) are stochastically bound to CpG islands (Klose et al., 2013). 
PRC1/2 complexes massive occupancy impedes transcriptional activation mediated by 
Trithorax proteins.  
 
Another minor mechanism employed for the recruitment of Polycomb proteins to 
chromatin is mediated by long non-coding RNA (lncRNA), non-protein coding transcripts 
implicated in different processes as transcription, post-transcriptional and epigenetic 
regulation. X-chromosome inactivation during dosage compensation in mammals is 
mediated by the lncRNA Xist that allows the recruitment of PRC2 proteins and, 
consequently, deposition of H3K27me3 repressive mark (Kohlmaier et al., 2004; Leeb & 
Wutz, 2007).  
 
PRC1 and PRC2 complexes are found in plants, animals and fungi (exceptionally, PRC1 is 
absent in the latter kingdom) suggesting an evolutionary conserved function (Lewis, 2017). 
Making the core of PRC1 complexes, RING1A, RING1B and their paralogs are the most 
conserved Polycomb products 
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1.2. RING1 proteins 	
1.2.1   Structure and H2A modifying activity 	
RING1B and its paralog RING1A were first identified in mammalian cells (Schoorlemmer 
et al., 1997). Named after the product of the original RING1 gene, one of the Really 
Interesting Genes (Lovering et al., 1993), they were found through their association with an 
homolog of one of the then well known in Drosophila PcG of proteins. RING1A and 
RING1B are proteins of 406 and 336 amino acids, respectively, and shared 67% of 
homology. (Fig.I1). They are metalloproteins with a N-terminal module that contains a 
RING finger motif (Lovering et al., 1993), and a C-terminal module contains a ubiquitin-
like motif also known as RAWUL (from RING and WDR ubiquitin-like, (Sanchez-Pulido 
et al., 2008), important for the association with CBX and RYBP PcG subunits (Garcia et 
al., 1999; Schoorlemmer et al., 1997)  
 
 
 
 
 
 
 
 
 
 
 
 
The only known substrate of E3 ligases containing RING1A and RING1B is histone H2A. 
In vitro studies with isolated or reconstituted PRC1 complexes indicate that the modification 
occurs only when histone H2A is in nucleosomal but not in free form. The demonstration 
that it is lysine 119 (and to a lesser extent 120 too) in the C-terminal tail of histone H2A the 
amino acid modified with monoubiquitin has come from mass-spectrometry analysis 
(McGinty et al., 2014). About 10-15% of histone H2A is mono-ubiquitylated in 
mammalian cells at a given time, comprising a large portion of the total pool of cellular 
ubiquitin. It is widely accepted that nucleosomes enriched in such a modified histone 
correlate with a transcriptionally silent state (Cao et al., 2005; Di Croce & Helin, 2013). 
The molecular structure needed for nucleosome binding and proper location at H2A 
Introducción
histocompatibilidad (Hanson et al. 1991; Lovering et al. 1993; Saurin et al. 1996). 
Contrariamente a lo sucedido con el resto de subunidades PcG, la caracterización de RING1A 
y RING1B tuvo lugar en vertebrados antes de la caracterización de sus homólogos SCE en 
Drosophila (Fritsch, Beuchle, and Müller 20 3; Gorfi kiel et al. 2004).  
Los genes Ring1A y Ring1B codifican proteínas de 406 y 336 aminoácidos 
respectivamente, presentando un 67% de identidad entre ellas (Schoorlemmer et al. 1997). La 
comparación de ambas proteínas reveló dos dominios proteicos conservados. El primero se 
encuentra en el extremo amino terminal, que contiene una región rica en residuos de cisteína 
conservada en otras muchas proteínas al que se denominó RING finger (Lovering et al. 
1993). Este dominio consta de tres láminas beta antiparalelas, una alfa hélice y dos bucles de 
unión a Zn2+, necesarios para su correcto plegamiento (Borden 2000). El segundo dominio 
contiene dos regiones de identidad de las proteínas RING1 que forman el llamado dominio 
RAWUL (por Ring-finger And WD40 associated Ubiquitin-Like) (Sanchez-Pulido et al. 
2008). Este dominio constituye una región esencial para la unión a otras subunidades PcG 
como CBX y RYBP (Schoorlemmer et al. 1997; Garcia et al. 1999) 
4.1 Ubiquitinación mediada por RING1A y RING1B 
La ubiquitinación de proteínas es llevada a cabo a través de una cascada enzimática 
formada por las enzimas E1, E2 y E3. Mediante un proceso secuencial la E1 activa y 
transfiere la ubiquitina a la E2 conjugadora, tras lo cual, de forma dependiente de la E3, la 
ubiquitina se une a un residuo de lisina de la proteína diana. La familia de las proteínas E3 
ligasas RING, a la cual pertenecen RING1A y RING1B de PRC1, sirven de unión entre la E2 
!21
11 158 261 306 354 406 
14 161 225 284 270 336 
RING1A
RING1B
RING
RING
RAWUL
RAWUL
Figura 3. Esquema de las proteínas RING1. En colores se muestran los dominios de homología. Los números 
representan los residuos de aminoácido del extremo amino al carboxilo. 
Figure I1. Schematic representation of RING1 proteins. Homology 
domains are represented with colors. Numbers indicate amino acids.  
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residue to efficiently transfer the ubiquitin requires the heterodimerization with the PCGF 
subunit, well documented for PCGF4/BMI-1(McGinty et al., 2014). 
 
 
1.2.2. Mechanisms of gene repression 
 
As members of Polycomb group, RING1A and RING1B act as transcriptional repressors 
through, at least, two well-know mechanisms: i) regulating RNA polymerase II activity; and 
ii) compacting the chromatin, making it inaccessible to others genome regulators. (Aranda 
et al., 2015; Di Croce & Helin, 2013). 
 
At PRC1-binding regions CpG islands two histone marks can be present, H3K4me3 and 
H3K27me3, normally associated to an ‘’active’’ and ‘’repressive’’ transcriptional state, 
respectively. When both marks are present at the same time, the promoter is called 
‘’bivalent’’ and the RNA polymerase II is paused as it cannot start transcription. Bivalent 
promoters are normally repressed in pluripotent cells. Once differentiation stimulus occurs, 
only one of the two histone marks is maintained, determining the expression/repression of 
the gene (Azuara et al., 2006; Bernstein et al., 2006; Cui et al., 2009; Mikkelsen et al., 
2007). For these reasons, inactivation of PRC1 or PRC2 proteins in ES cells may induce 
premature de-repression of genes that normally control the self-renewal process and 
pluripotency state (M Endoh et al., 2008; Pasini et al., 2007; Shen et al., 2008). 
 
Presence of H2Aub affects the binding and transcriptional activity of RNA polymerase II. It 
has been demonstrated that loss of RING1 proteins and, consequently, of the H2Aub mark, 
allows an increased recruitment of RNA polymerase II to promoters and transcription 
initiation (Endoh et al., 2012; Stock et al., 2007). Presence of H2Aub seems also to interfere 
with the elongation process during transcription (Zhou et al., , 2008). 
 
 
Chromatin compaction is another mechanism mediated for PRC1 and PRC2 proteins that 
regulates gene expression (King et al., 2005; R.Margueron et al., 2008). In ES cells lacking 
RING1B, FISH (fluorescent in situ hybridization) assays demonstrate that Hox genes are 
activated and physically separated from the rest of cluster, due to a diminished chromatin 
compaction (Eskeland et al., 2010). Surprisingly, the RING1B capacity to compact 
chromatin may well be independent from its E3 ligase activity (Eskeland et al., 2010; 
Illingworth et al., 2015). 
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Chromatin compaction has been proposed as a way to physically impede the access of 
other chromatin remodeler, such as SWI/SNF complex (Francis et al, 2001; Levine et al., 
2002), necessary for transcription activation. 
 
1.2.3. Transcriptional targets 
 
PRC1 complexes are widely considered as chromatin regulators for negative modulation of 
transcription. However, recent, detailed studies in fly and mammalian cell systems describe 
the presence of PRC1 products on transcriptionally active loci. This asks for a re-evaluation 
of the accepted function of PRC1 complexes as transcriptional repressors (Kloet et al., 
2016). Nevertheless, most work approaching PRC1 rol(es) in gene control has been a quest 
to understand the repressive mechanisms involved. Questions currently under investigation 
are those concerning recruitment of Polycomb complexes to their targets and how 
transcription is affected at Polycomb-modified chromatin.  Location of PcG products on 
TSSs is predominant, but not exclusive and binding to gene bodies and enhancers, 
although less studied, is also found (Entrevan et al., 2016). 
 
Original observations in Drosophila proposing PRC1 as transcriptional repressors, was 
corroborated in loss-of-function models in mammals and plants (Aranda et al., 2015; 
Lanzuolo & Orlando, 2012; N. Reynolds et al., 2013; Whitcomb et al., 2007). A seminal 
study, in murine embryonic stem cells (ESC), shows association of PRC1 and PRC2 
products with regulatory sequences of hundreds of genes with roles in the major 
developmental pathways (Boyer et al., 2006). The data suggested that ESC pluripotency 
was maintained through the repression of these genes before they were called to direct 
commitment and specification processes of cell differentiation. In fact, the overall activity of 
Polycomb complexes is more important for actual differentiation than for the maintenance 
of the ESC state, and that only PRC1 but not PRC2 act as an efficient repressors of any 
relevance to the ESC state (Bracken et al., 2006, Boyer et al., 2006)). 
 
In other genetic models, such as loss-of-function of Polycomb products in hematopoietic, 
neural or epidermal compartments, the outcomes have been rather modest, far from 
outright deviations from differentiation pathways as it might have been expected from 
initial hypothesis. Interestingly, a common observation in these models is that phenotypic 
alterations related more to deregulated proliferation than to cell identity gene expression 
changes, that prominently affect, although not exclusively, repression of cell cycle inhibitors 
(Bracken et al., 2007; Bravo et al., 2015; Calés et al., 2008; Fasano et al., 2007; Iwama et 
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al., 2004; Lessard & Sauvageau, 2003; Jacoobs et al., 1999; Molofsky et al., 2003, 2005; 
Piunti et al., 2014; Román-Trufero et al., 2009).  
 
2. PRC1 in cell proliferation  
2.1. Cell cycle control through CDK inhibitors 
 
For Polycomb proteins, somehow, the selective use of the coding potential of the genome, 
generating gene expression patterns specific to each cell type has attracted more attention 
than the control of genes important in cell proliferation. And yet, multicellular organisms 
can only result from the balanced generation of appropriate numbers of specialized cell 
types, both during development and during tissues maintenance in the adult. Thus, 
differentiation programs or responses to cellular stress include exquisite control of cellular 
proliferation (Weissman, 2000).  
 
Cell multiplication coordinates a myriad of processes, from sensing proliferative signals to 
the initiation of the replication of the genome and the segregation of duplicated 
chromosomes into daughter cells. These processes occur in sequential steps or phases, 
defining the so-called cell cycle or period between cell division events. DNA replication 
occurs in S-phase and actual division of the cell with duplicated genome takes place in 
mitosis. Between these steps is the G2 phase and the period following cell division and 
initiation of DNA replication is G1 (Vermeulen et al., 2003). Many chromatin regulators, 
besides Polycomb, participate decisively in the progression of the cell cycle (Fig.I2) (Pasini, 
Bracken, & Helin, 2004).  
 
The successive phases of the cell cycle are regulated by the periodic accumulation (and 
destruction) of cyclins specific for each of the phases. For example, cyclins D are relevant in 
G1, cyclins E in the transit from G1 to S and cyclins A and B in S, G2 and mitosis (Bertoli 
et al., 2013). Oscillations in the levels of cyclins impacts the activity of kinases (cyclin-
dependent kinases, CDKs) that determine the activity of genes required to enter the cell 
division and a plethora of other processes (Gérard & Goldbeter, 2012). Cells spend most of 
the time in G1, a period in which promoters of genes encoding products required for 
proliferation is silenced by recruitment of non-phosphorylated members of the 
retinoblastoma gene family. When the strength of proliferation signal builds up, cyclin D-
CDK4/6 complexes gain kinase function and E2F transcription factors, released from 
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inactivating retinoblastoma by phosphorylation-dependent eviction, engage transcription at 
cell proliferation-specific promoters (Giacinti & Giordano, 2006).  
In addition to cyclins, the activity of G1-specific kinases is also controlled by the so-called 
CDK inhibitors (CDKIs), structurally unfolded small proteins that bind cyclin-CDK 
complexes inactivating their kinase function (Bruggeman & Van Lohuizen, 2006). These 
CDKIs are constitutively deficient in transformed conditions and are among the best-
studied tumor suppressors.  
 
Of these, the products of the Cdkn2a gene, p16-INK4a and p19-ARF in the mouse, two 
polypeptides generated by alternative use of promoters and partial differential splicing 
(Haber, 1997), inhibit CDK4/6 and are transcriptionally repressed by Polycomb products. 
In primary mouse embryonic fibroblasts deficient in BMI-1 a causal relationship between 
senescence (proliferative arrest) caused by upregulation of p16-INK4a and the absence of a 
Polycomb product was first observed (Jacobs et al., 1999). We also observed cell cycle arrest 
in differentiating hematopoietic precursors lacking RING1B which was reverted by a null 
mutation in the Cdkn2a gene (Calés et al., 2008).  CDKN2B upregulation has also been 
reported in hematopoietic progenitors with decreased FBXL10/KDM2B (He et al., 2009). 
Effective control of genes in the Cdkn2 cluster is considered important for the maintenance 
of adult pluripotent progenitors, the cells with the developmental potential required to 
replenish tissue compartments under physiological or pathological attrition. 
 
Another decisive regulator of the cell cycle, p21/CDKN1A, inhibits cell cycle progression 
mainly by inhibiting cyclin E/CDK2 (Fig.I2). The activity of this kinase is strictly required 
to achieve irreversible commitment to proliferation and initiate DNA replication (licenses 
replication origins) (Porter, 2008). Transcriptional control of p21/Cdkn1a has been 
extensively studied. Best known pathway that end in upregulation of this CDKI is the 
elicited by various cellular stresses, that lead to transcriptional activation of the gene by 
p53-dependent and p53-independent (Ras/Raf/MAPK/E2F-dependent) mechanisms 
(Abbas & Dutta, 2009). However, the control involves a plethora of diverse regulators that 
include not only transcription activators but also inhibitors, making the picture extremely 
complex and not fully understood. Inactivation of PRC1 subunits in some models of 
progenitor cells correlates with upregulation of p21/Cdkn1a at the mRNA and/or protein 
level (Fasano et al., 2007; Koike et al., 2014; Román-Trufero et al., 2009), but to date, no 
mechanism or function has been elucidated. 
Additionally, high levels of p21/CDKN1A are often associated to senescence pathways 
triggered by cellular stress like damaged DNA (Cazzalini et al., 2010; Ciccia & Elledge, 
2010; Karimian, Ahmadi, & Yousefi, 2016).   
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2.2.   p21 and G1/S checkpoint: DNA damage control 
 
One of the essential functions of CDKIs, in particular p21/CDKN1A, is to stop cell cycle 
in response to various stimuli (stresses) that put at risk proper genetic duplication and cell 
division. This checkpoint function transiently delays the progress at specific junctions 
(G1/S, intra S, G2/M) to allow the cell to deal or repair whatever damage has been 
inflicted, ultimately assuring genomic integrity (Abbas & Dutta, 2009; Karimian et al., 
2016).  
 
One of the most common and harmful damage for the cell is that affecting DNA. This 
occurs frequently after exposure to external agents such as irradiation (UV, XRays, 
radiochemicals) or chemicals (drugs, additives, cigarette smoke) that can provoke severe 
alterations of the DNA structure. Additionally, an important source of DNA damage also 
results from physiological metabolic processes, i.e. endogenous toxic accumulation of 
reactive oxygen species (ROS), products of cellular metabolism or alteration of redox 
homeostasis (Lombard et al., 2005;Wagner, 2013). Presence of high levels of ROS can 
cause several types of DNA lesions as breaks, adducts, and cross-links. The best known 
alteration is the 8-oxo-guanine (8-oxoG) base modification (Lindahl, 1993; Wagner, 2013). 
When this kind of lesions are not properly removed and replicative or transcriptional 
machinery encounter it, single-strand breaks (SSB) and double-strand breaks (DSBs) may 
be generated (Burhans & Weinberger, 2007; Woodbine et al.,  2011). These can also occur 
through direct, potent genotoxic aggression.  
 
When cells acquire DNA damage, a highly organized and coordinated cellular process, 
called DNA Damage Response (DDR) (Ciccia & Elledge, 2010), counteracts genotoxic 
stress, assuring that, if damage remains unrepaired or is not fixed within a reasonable time-
frame, senescence or death by apoptosis or by autophagy will take place (Sancar et al., 
2004; Sherman et al., 2011)  
 
DDR starts by sensoring the molecular alterations, then activating a signaling orchestrated 
by ATM/CHK2 and ATR/CHK1 kinases cascades, that may work together but which 
have non redundant functions (Maréchal & Zou, 2013). Ionizing radiations-induced DSBs 
are potent activators of ATM pathway, whereas stalled DNA replication forks and 
replicative stress elicit ATR branch (Adams, Golding, Rao, & Valerie, 2010; Smith et al., 
2010). ATM/ATR kinases substrates comprise numerous proteins (e.g. nucleases) involved 
in repairing the DNA damage (Jazayeri et al., 2006), or favoring apoptosis, but also 
primarily factors that will ensure checkpoint activation, thus cell cycle arrest. One of these is 
Introduction		
18	
	
the tumor suppressor P53, with multiple targets such as p21/CDKN1A, that assures the 
temporary halt of phases progression (Shieh et al., 1997). However, P53 has multiple other 
targets that include proteins involved in DNA repair, in cell apoptosis, autophagy or 
senescence. P53 is induced not only by DDR, but also in response to other stresses. Its 
accumulation and post-translational modifications determine cells outcome, e.g. cell cycle 
arrest or apoptosis (Kracikova et al., 2013; Sherman et al., 2011). P53 is phosphorylated by 
ATM at serine 18 (serine 15 in human) and further phosphorylated by CHK1 and CHK2 
and that result in the stabilization of this protein with a rather high basal turnover (Lakin & 
Jackson, 1999; Mendrysa et al., 2011; Smith et al., 2010).  
 
 
2.3. PRC1 non-transcriptional functions 
2.3.1. RING1B role in DNA replication 
 
As already mentioned, recent evidences support a non-transcriptional, direct role of PRC1 
proteins in controlling cell proliferation.  
 
RING1B on nascent DNA and the presence of RING1A on the maturing chromatin 
following the formation of nascent DNA (Alabert & Groth, 2012; Lee et al., 2014; Piunti et 
al., 2014) suggests that RING1 proteins have a role in DNA replication. Work in our 
laboratory has shown that RING1-deficient mouse embryonic fibroblasts (mEFs) display 
sign of replicative stress due to the presence of slower or stalled replication forks (Bravo et 
al., 2015), in particular in sensible regions as pericentric heterochromatin, PCH (Branzei & 
Foiani, 2010). The presence of H2Aub at PHC is essential to assure a correct DNA 
replication. Replicative stress could culminate with the presence of signs of double-strand 
breaks affecting genome integrity (Bravo et al., 2015). In this context, concurrent 
inactivation of RING1 proteins and knock-down of p21/Cdkn1a could only temporally 
restore the p21-mediated proliferative defect (Bravo et al., 2015). 
 Others groups reports have also contributed to unveil the presence of RING1 proteins on 
nascent DNA suggesting a critical role of PRC1 proteins in avoiding replicative stress-
derived activation of DNA damage response that could affect cell cycle progression.  
Immortalized fibroblasts with oncogenic overexpression were used for the study, and this 
may have added exogenous, non-physiological, replicative stress (Piunti et al., 2014). Also, 
Nascent Chromatin Capture (NCC) technique coupled with quantitative proteomics 
performed in human cells also has allowed to identify RING1A and RING1B on biotin-
dUTP labeled nascent DNA (Alabert & Groth, 2012). 
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2.3.2. Other PRC1 functions affecting DNA biology  
 
Collectively, the data above are telling about the limited view of RING1B role as 
transcriptional repressor and thus, that PRC1 functions may affect other aspects of DNA-
related processes such as the described direct role in DNA replication, but that could also 
affect DNA damage, DNA repair and/or some of the pathways that lead to DDR such as  
oxidative stress, as it has already been explored (Liu et al., 2009; Vissers Joseph H. A., 2012). 
For instance, BMI-1 has been reported to be involved in redox homeostasis in different cell 
types (Banerjee Mustafi et al., 2016; Chatoo et al., 2009; Liu et al., 2009). Also, the presence 
of PRC1 components has been detected at site of ionizing radiation (IR)- and laser-induced 
double-strand breaks (Chou et al., 2010; Facchino et al., 2010; Ginjala et al., 2011;  Ismail et 
al., 2010). The protein recruitment kinetics was similar to that of other proteins involved in 
DNA damage response as NBS1 and RNF8 (H. Ismail et al., 2010). That involved PCR1 
proteins in the earliest signaling and amplification steps of DDR (Lukas et al., 2011). Also 
recently, it was described that ATM-dependent phosphorylation of the elongation factor 
ENL allows the recruitment of PRC1 proteins (BMI-1 and RING1B) to the site of DSBs. 
This induced transcriptional repression (H2Aub) and allowed DNA repair proteins access to 
DSBs (Ui et al., 2015).  
 
Ubiquitination of histone H2A has also been suggested to be implicated in DNA 
damage signaling and transcriptional silencing of surrounded regions close to DSBs 
(Bergink et al., 2006; Vissers et al., 2012) suggesting that E3 ligase activity of RING1 
proteins could be playing an important role.  
 
All these evidences point at functions of PRC1 related to DNA that could define a 
much broader task for these proteins.   
 
3. Cell models of PRC1 role in cell proliferation 
 
3.1. Hematopoietic cells 
 
Loss of function studies in the hematopoietic system showed that PcG products act as 
positive regulators of cell proliferation. In particular, hematopoietic stem cells proliferation 
and self-renewal capacities are linked to the activity of PRC1 proteins to repress the 
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Ink4a/Arf locus (Fig.I2). De-repression of this locus in BMI-1 deficient hematopoietic cells 
equally induces a higher expression of p16-INK4a and p19-ARF that interferes with cell 
cycle progression, in particular at G1 to S phase transition (Iwama et al., 2004; Lessard & 
Sauvageau, 2003; Park et al., 2003).  As mentioned before, our  
 
 
laboratory has described that loss of RING1B differentially affected immature and mature 
hematopoietic compartments. In lineage negative cells, RING1B loss induces a transient 
hyperproliferation effect, but in more mature cells upregulation of p16-INK4a is the 
principal mediator of proliferative arrest, as Cdkn2a null mutation is able to rescue the 
phenotype (Cales et al., 2008)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2. Neural stem/progenitor cells and PRC1 proteins role on 
proliferation 
 
The central nervous system originates in neural stem cells (NSCs), progenitor cells located 
in the neuroectoderm, an epithelial structure in the early embryo. Its expansion, through 
symmetric divisions of NSCs, and closure gives rise to a neural tube whose inside is lined by 
NSCs. By the onset of neurogenesis, day 9-10 of development in the mouse, NSCs 
transform in another pluripotent cell type with fewer epithelial feature, the radial glial cells 
(RGCs) (Götz & Huttner, 2005; Guillemot, 2007; Temple, 2001). From this pool of 
Figure I2.  Schematic representation of cell cycle and PRC1 control 
on some CDK inhibitors. 
G1
S
G2
M
Cyclin E
Cdk2
DNA damage
Cyclins D
Cdk4, 6
p16
p21
p53
PRC1
p15
PRC1
Introduction		
21	
	
progenitors, asymmetrically, a RGC and an intermediate progenitor cell are generated. 
Subsequently, during neurogenesis (days 14 to 16) symmetric and asymmetric divisions of 
intermediate progenitor cells (IPCs) located in more basal positions, away from ventricular 
surfaces, give rise to neurons. The population of progenitors evolves with time and at a later 
time, by day 18, no neurons are formed and, instead, astrocytes, a type of glial cells, are 
produced (see review by Pinto & Götz, 2007). Cultures of NSCs and pluripotent 
progenitors can be established from dissociated explants of select portions (subventricular 
zone of adult mice or olfactory bulb) (W. Guo et al., 2012; Vicario-Abejon et al., 2003) of 
the developing nervous system. Cells in these cultures grow as spheroid structures known as 
neurospheres and contain a mixture of NSCs and other progenitors with a high self-
renewal potential and, when provided appropriate signals, able to differentiate into 
neuronal and glial cell types (Reynolds & Rietze, 2005; Reynolds & Weiss, 1996) Previous 
work in our laboratory has shown that upon deletion of Ring1B, spontaneous neuronal 
differentiation occurs in a fraction of the progenitors, which becomes more noticeable when 
RING1A redundancy is eliminated in double mutant cells (Román-Trufero et al., 2009).  
Similar to the hematopoietic system, the PcG products act as positive regulators of 
proliferation also in NSCs. RING1B-deficiency induces upregulation of different CDK 
inhibitors, among that p16-INK4a and p21/CDKN1A, and other genes correlated with 
P53 function. ChIP-on-ChIP analysis shows that RING1B does not directly bind 
p21/CDKN1A promoter, suggesting additional, unexplored, mechanism that induced p21 
upregulation and proliferation defect (Román-Trufero et al., 2009).  BMI-1 knock-out also 
induces a proliferative defect in vivo as in vitro, more accentuated in adult mice or post-natal 
derived neurospheres respect to embryonic phase (Molofsky et al., 2003). Bmi-1 and Ink4a 
double inactivation only partially restore number, self-renewal and proliferation capacities 
of NSCs (Bruggeman et al., 2005; Molofsky et al., 2003, 2005), suggesting the implication 
of p16-INK4a but that others mechanisms could be participate. In 2007, Fasano and 
colleagues demonstrated that p21/CDKN1A is the mediator of the proliferative defect after 
knock-down of Bmi-1 in fetal and adult NSCs (Fasano et al., 2007). Curiously, no 
upregulation of Ink4a/Arf products was observed. Probably, p21/CDKN1A upregulation 
was interpreted as removal of repressing influence (BMI-1) but not clear evidences 
supported this hypothesis.   
The role of RING1B on cell proliferation has been only partially studied. The evidence 
points at the presence of PRC1 proteins in fundamental processes such as redox 
homeostasis, DNA damage and DNA replication suggests that RING1B could positively 
control cell proliferation independently of its well-known role as transcriptional repressor or 
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its E3 ligase activity. Also to date, the pathways involved in PRC1 positive control on NSCs 
self-renewal and proliferation have not been clarified. 
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Objectives 	
 
We aimed at investigating the mechanism(s) involved in RING1B promotion of 
proliferation using a cellular model of murine embryonic NSCs, pursuing the 
following objectives: 
 
1. To study the relationship between RING1B as a proliferation activator and CDK 
inhibitors 
 
2. To determine the putative implication of RING1B in endogenous triggering of 
p53-dependent DNA damage response.  
 
3. To explore possible mechanisms involving other PRC1 subunits. 
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1. Mouse strains  
 
Ring1B conditional knockout (Fig.M1) and genotyping were described previously (Cales et 
al., 2008). Inducible Cre-expressing mouse lines were Polr2a::CreERT2 (Mijimolle et al., 2005) 
and Rosa26::CreERT2 (Seibler et al., 2003). Compound Ring1Bf/f;P53-/-, Ring1Bf/f;Ink4a-/- and 
Ring1Bf/f;Cdkn1A/p21-/- were obtained crossing Ring1Bf/f; Polr2a::CreERT2 or 
Ring1Bf/f;Rosa26::CreERT2 mice with P53-/- (Jacks et al., 1994), Ink4a-/- (Serrano et al., 1996) 
and Cdkn1A/p21-/- (Brugarolas et al., 1995) mouse lines, respectively. Mouse embryonic 
fibroblasts (mEFs) were obtained from Bmi-1-/- (Jacobs, et al,  1999), Ring1A-/- (del Mar 
Lorente et al., 2000) and Ring1Bf/f; Polr2a::CreERT2 (Cales et al., 2008). 
 
Translocation of Cre-ERT2 to cell nuclei and loxP recombination were achieved by adding 
to the cultures 4’-hydroxytamoxifentamoxifen (4’-OHT, 1μM final concentration; Sigma-
Aldrich) or vehicle (+4’-OHT or -4’-OHT, respectively). 
 
 
2. Cell culture: 
2.1. Primary cells 
2.1.1. Neural Stem/Progenitor Cell Culture 
 
Neural stem cells were prepared from mouse embryonic olfactory bulbs (OBs) on the 
gestational days E13.5, considering E0.5 the day on which a vaginal plug was found in the 
pregnant female. After taking the brain out of the skull, the OBs (Fig.M2) were dissected 
using a sterile razor blade. Cells of dissected OBs were obtained by combining mechanical  
Figure M1: Strategy for generation of Ring1BΔ/Δ cells. ATG denotes 
the initiation codon of Ring1B, red triangles loxP sequences and filled 
boxes Ring1B exons (Román-Trufero et al., 2009). 
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dissociation (pipetting with sterile 100µL tips) and treatment with Hank's buffered salt 
solution (HBSS) supplemented with 0.025% of EDTA (HBSS+EDTA) for 20 minutes  
at 37°C in a 5% CO2 atmosphere. After washing with Hank's buffered salt solution (HBSS) 
(without EDTA), cells were resuspended in DMEM/F-12 (1:1) (Life Technologies) including 
HEPES buffer (5 mM), glucose (0.6%), sodium bicarbonate (3 mM), and glutamine (2 mM). 
A defined hormone and salt mixture composed of insulin (25 mg/ml) apo-transferrin (100 
mg/ml), progesterone (20 nM), putrescine (60 mM), and sodium selenite (30 nM) (all from 
Sigma-Aldrich) was used instead of serum. During NSCs viral transduction, B27 serum 
supplement (Gibco) was added to the medium to improve cell survival and proliferation. 
Freshly derived OB stem cells (OBSCs) 
were plated on uncoated tissue culture 
dishes at a density of 35,000 cells per 
square centimeter, and incubated at 37°C 
in a 5% CO2 atmosphere. FGF-2 and 
EGF (20 ng/ml each) were added daily to 
expand the proliferative precursor cell 
population (Vergaño-Vera et al., 2006)  
Once neural stem/progenitor cells culture 
was established, cells were seeded at 5000 
cells per square centimeter and grown as 
floating aggregates or “spheres” (B. A. Reynolds & Weiss, 1996) and passaged every 3–5 
days. At this point, the neurospheres should be passaged to prevent the cell clusters from 
growing too large, which can lead to necrosis as a result of a lack of oxygen and nutrient 
exchange at the neurospheres center. During passages, cells were dissociated using 
HBSS+EDTA buffer as described previously.  
 
For immunofluorescence and ROS detection assay, NSCs were grown as monolayer culture. 
6-wells plates (ROS detection) or glass coverslips (Thermo Scientific) were treated with 
15µg/ml of poly-L-ornithine hydrobromide (Invitrogen) for 16 hours, washed with 1X PBS 
(3x) and treated with 1µg/ml bovine plasma fibronectin (FN) (Sigma-Aldrich) for at least 4 
hours. Poly-L-ornithine is a synthetic amino acid chain that is positively charged and widely 
used as a coating to enhance cell attachment and adhesion to both plasticware and glass 
surfaces. FN is a multifunctional extracellular matrix glycoprotein used as cell adhesion 
molecule. Neurospheres were dissociated after a conventional passage as described before  
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Figure M2. The principal regions of the 
embryonic nervous system. NSCs have been 
isolated from the OBs. 
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and seeded at a density of 10.000 cells/cm2 directly on treated-coverslips or wells. Mitogens 
were added daily to avoid cells differentiation. For clonal analysis, neurospheres were 
dissociated into a single-cell suspension and diluted to eight cells/ml in a mixture 1:1 of 
DMEM/F12/N12 and OBSC-conditioned medium (OBSC-CM, medium where the 
neurospheres were grown for 4 days). Neurospheres were centrifuged and supernatant 
(conditioned medium) was filtered through with 0.2µm filter.  Two hundred microliters of 
the 8 cells /ml suspension was plated into each well of 96-well plates (1.6 cells/well). One day 
after seeding, wells containing a single cell were marked and induced to proliferate for 9 
days, when the wells were screened for the presence of clonal neurospheres.  
Phase contrast neurospheres photographs were acquired with DM IL LED microscope 
(Leica). Neurospheres diameters were calculated using ImageJ software. 
 
2.1.2. Mouse embryonic fibroblasts (mEFs) 
 
Mouse embryonic fibroblasts (MEFs, passage +2) were established from Ring1Bf/f, Polr2a:Cre-
ERT2 , Bmi-1-/- or Ring1A-/-  E13.5 embryos. After dissect head and red organs, embryos were 
washed in PBS and finely minced using a sterile razor blade until it becomes possible to 
pipette. mEFs were seeded at a density of 300.000 cells/10cm-plate or 100.000 cells/6cm-
plate at day 0 and grown in Dulbecco’s modified Eagle’s medium (DMEM; Biowest) 
supplemented with 10% fetal bovine serum (heat-inactivated FBS, Sigma-Aldrich-Aldrich) 
and 100U/ml of antibiotics (Pen-Strep, Thermo Fisher) at 37ºC, in a 5% of CO2 
atmosphere. To induce Ring1B recombination, 4′-OHT (1 μM, Sigma-Aldrich-Aldrich) was 
added to the culture for 16 h. Control cells were treated with same amount of vehicle 
(Ethanol=-4-‘OHT). Analysis was performed 96 hours after treatment initiation.  
 
2.2. Established cell lines 
 
Murine NIH-3T3 cell lines were grown in DMEM medium (Biowest) supplied with 10% 
Fetal Calf Serum (heat-inactivate, Sigma-Aldrich) and 100U/ml of penicillin/streptomycin 
antibiotics (Thermo Fisher). 
293T cell line is a highly transfectable derivative of human embryonic kidney 293 cells, and 
contains the SV40 T-antigen. 293T cells were cultured in high glucose DMEM (Biowest)  
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with 10% heat-inactivated Fetal Bovine Serum (FBS, Sigma-Aldrich) and 100U/ml of 
penicillin/streptomycin antibiotics (Thermo Fisher). 
3. Cell immunostaining 
 
NSCs, seeded at 10.000 cells/cm2 at day 0 of the experiment, were grown as monolayer 
culture as described in section 2.1.1. on sterile glass coverslips for four days in presence of 
EGF and FGF-2. 
mEFs were seeded at 100.000 cells/6cm-plate on sterile glass coverslips. At day +4 after 4’-
OHT treatment, cells were pulse-labelled with EdU (10 μM) and fixed in 4% 
paraformaldehyde (PFA, Pierce) for 11 minutes, permeabilized with 0.5% Triton X-100 in 
PBS and blocked for 30 min in TPBS (0.1% Tween-20-containing PBS) containing 1% 
gelatin from cold water fish skin (Sigma-Aldrich) and 10% goat serum (blocking buffer). In 
order to detect insoluble RPA32, cells were fixed with 1% PFA/PBS for 1 min, pre-extracted 
with 0.5% Triton X-100 in PBS for 5 min, and fixed in 3%PFA/PBS for additional 15 min 
at room temperature. Incubation with primary antibodies (diluted in blocking buffer, see 
Table M1) was for 1 h at room temperature or at 4°C overnight. After washes, coverslips 
were incubated with 1µg/ml of Alexa-Fluor-conjugated goat antibodies (Alexa Fluor 488 or 
568, Life Technologies), for 1 h at room temperature. After three washes in TPBS, DNA was 
stained for five minutes with 2 μg/ml 4’,6-diamino-2-phenylindole (DAPI) diluted in TPBS.  
 
Cell proliferation was assessed by 5-ethynyl-2'-deoxyuridine (EdU) incorporation (ten 
minutes pulse-labelling at 10µM final concentration directly in culture medium) with Click-it 
EdU Alexa Fluor 488 or 647 imaging kit (Life Technologies) according to the manufacturer’s 
instructions. Detection is based on a click reaction, a copper-catalyzed covalent reaction 
between an azide and an alkyne. In this application, the EdU contains the alkyne and the 
Alexa Fluor dye contains the azide. The advantages of the Click-iT EdU labeling are that the 
small size of the dye azide allows for efficient detection of the incorporated EdU using mild 
conditions. Standard aldehyde-based fixation (4% PFA for eleven minutes) and detergent 
permeabilization (0.5% Triton X-100/PBS during 20 minutes) are sufficient for the Click-iT 
detection reagent to gain access to the DNA.  
Coverslips were mounted using Mowiol (Calbiochem). Confocal images (confocal z-planes 
acquired every 0.5μm) were acquired using a LEICA TCS-SP5-AOBS microscope with an 
oil immersion 63× or 40x HCX PL APO objective lens. The nuclei were outlined using  
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DAPI staining as a template and copied to the appropriate fluorophore channel. Nuclei were 
then counted and measurements of the mean fluorescent intensity or number of foci were 
recorded using ImageJ software. Background was determined in images from incubations 
without primary antibody and was subtracted so that only the ‘true signal’ was analyzed with 
the Find maxima tool from the ImageJ software.  
A list of antibodies used for immunostaining is presented in Table M1. 
 
4. Apoptosis assays 
 
Apoptotic cells were scored using Annexin-V–FITC apoptotis detection kit (Bender 
MedSystems). Neurospheres cultured for 4 days after EtOH/4’-OHT treatment were 
dissociated into a single-cells suspension, washed once in PBS followed by a wash with the 
provided 1x binding buffer. Then cells (1×106/ml, 0.1 ml) in binding buffer containing 5μl of 
FITC-conjugated Annexin V and incubated for 10 minutes at room temperature. After 
washes with the provided 1x binding buffer, 10 μl of Propidium Iodide (20 μg/ml) staining 
solution were added and cells were acquired with DIVA software in a FACS Canto 
cytometer (both from Becton Dickinson) and analyzed using FlowLogic software (Inivai 
Technologies). Apoptosis was also assessed by conventional immunofluorescence (as above) 
using an anti-active caspase-3 (Promega). 
 
5. Western Blot Analysis 
 
Cells were lysed in Radioimmunoprecipitation assay buffer (RIPA, 10 mM Tris-HCl, pH 
7.2; 150 mM NaCl; 1% Triton-100; 0.1% sodium dodecyl sulfate; 1% sodium deoxycholate; 
5 mM EDTA, 1x PhosSTOP (Roche) and 1x Protease inhibitor cocktail (Biotools) for 15 
minutes on ice, followed by 3 cycles (30 seconds ON/OFF) of sonicator (Diagenode) and 
additional 15 minutes incubation on ice. Protein extracts were quantified using BCA protein 
assay kit (Thermo Scientific) following the manufacturer’s instructions. 15-30 μg of protein 
extract was subjected to SDS-PAGE electrophoresis (12% acrylamide in SDS PAGE gel) for 
55 minutes at 180V. Separated proteins were transferred to a nitrocellulose blotting 
membrane (GE Healthcare) for one hour at 100V. Membranes were blocked with 5% non- 
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fat dry milk (Chem Cruz) solubilized in 0.1% of tween-20 in PBS (blocking solution) and 
incubated with antibodies indicated in table 1 diluted in 1% Bovine Serum Albumin (BSA, 
Chem Cruz) in TTBS for two hours at room temperature or overnight at 4°C.  After 3 
washes in TTBS, membranes were incubated with the corresponding mouse (Dako) or rabbit 
(Life technologies) HRP secondary antibodies diluted in blocking solution at a final 
concentration of 0.2μg/ml for one hour at room temperature. Chemiluminescent reactions 
were performed using ECL Prime reagent (GE Healthcare) and luminescent signals were 
acquired on curix medical X-ray film (AGFA) or with ChemiDoc Touch Imaging System 
(Bio Rad). 
 
6. Intracellular ROS analysis 
 
For analysis of intracellular ROS, NSCs and mEFs were grown as monolayer in P60mm 
plates. At day +4, DCFDA (Sigma-Aldrich) was added directly in cell culture medium to a 
final concentration of 10 µM, and left at 37 °C for 30 min. DCFDA is a fluorogenic dye that 
measures hydroxyl, peroxyl and other reactive oxygen species (ROS) activity within the cell. 
After diffusion in to the cell, DCFDA is deacetylated by cellular esterases to a non-fluorescent 
compound, which is later oxidized by ROS into 2’, 7’–dichlorofluorescein (DCF).  NSCs 
monolayer cultures were detached with StemPro Accutase (0.5ml/6cm-plate, Thermo 
Scientific) at 37 °C for 5 minutes. mEFs were detached with 0.05% Trypsin-EDTA  
(1ml/10cm-plate, Gibco) at 37 °C for 5 minutes. Both NSCs and mEFs were immediately 
analyzed by Flow Cytometry using a EPICS XL (Beckman-coulter). Where indicated, N-
acetyl-L-cysteine (NAC, Sigma-Aldrich) was added directly in culture medium at a final 
concentration of 0.5mM in H20.  
 
7. Quantitative RT-PCR 
 
Total RNA was isolated lysing 5x106 NSCs using 1ml of TRI reagent (Sigma-Aldrich) for 5 
minutes at room temperature. Phases separation were performed adding 0.2ml/ml of TRI 
reagent of chloroform and centrifugation at 12.000x for 15 minutes at 4°C. Total RNA 
containing-aqueous phase was separated and RNA was precipitated adding 0.5ml of 2- 
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propanol and centrifugation at 12.000g for 10 minutes at 4°C. RNA was resuspended in 
RNase-free water and quantified with Nanodrop. 1µg of RNA was used to setup reverse 
transcription (RT) reaction, carried out using the iScript cDNA Synthesis Kit (Bio-Rad) 
according to the manufacturer’s guidelines. A quantitative polymerase chain reaction (qPCR)  
 
analysis was performed in duplicate using 1:10 or 1:100 diluted cDNA per reaction in a 
LightCycler 96 (Roche) with Bio-Rad SYBR-Green (Bio-Rad). β-Actin was the  
reference gene used for normalization. Relative gene expression was calculated using the 
comparative Ct method also referred to as the 2−ΔΔCT method. Sequences of primer pairs for 
the qRT-PCR are indicated in table M2. 
 
8. Vector Production and Viral Packaging 
 
Lentiviral particles were obtained upon co-transfection of 10μg of pFUGW-H1 (Fasano et 
al., 2007) or pTRIPZ (Thermo Scientific) plasmid into 293T cells with 4.8μg psPAX2 
packaging and 2.6μg pMD2G envelope plasmids (Addgene plasmids# 12260 and 1259, 
respectively). Viral containing media were collected, filtered, and 100-fold concentrated (only 
for NSCs transduction) by ultracentrifugation at 23000rpm for two hours at 4° C degrees 
using a Beckman Coulter ultracentrifuge and SW28 rotor. Viral titers were measured by 
serial dilution on NIH-3T3 cells. For viral transduction, 107   fresh viral particles were used to 
infect 106 single cell suspension of NSCs (MOI=10) in presence of 8 μg/mL of Polybrene 
(Sigma-Aldrich), 1x B27 serum supplement (Gibco), EGF and FGF2 (20 ng/ml each) and 
medium up to 1ml seeded in a well of 6 wells-plate. To improve transduction efficiency, 6 
wells-plate was centrifuged for 1 hour at 1500rpm (rotor A-4-63, Eppendorf 5810 R) at 4° C 
degrees. 
For viral transduction of mEFs, non-ultracentrifuged lentiviral vectors were diluted 1:2 with 
complete medium and incubated overnight with 100.000 cells/6cm-plate in presence of 
8μg/mL of polybrene (Sigma-Aldrich).  
A third-generation lentiviral vector pFUGW-H1 was used to express a shRNA to target the 
p21 ORF (TTAGGACTCAACCGTAATA and AGTAGCAGTTGTACAAGGA) (Fasano 
et al., 2007). The pTRIPZ lentiviral doxycyclin-inducible vector (Tet-On system, Thermo 
Scientific) was used to overexpressed a wild type or a E3 ligase mutant (IL53,55A,A; ∆E3) 
form of RING1B, or BMI-1 ORF. NSCs and mEFs transduced with pTRIPZ lentiviruses  
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were grown in presence of 1.1μg/mL of puromycin (Toku E) for 3 days to select only 
transduced cells. After antibiotic selection, cells were treated, or not (as control) with 2 
μg/mL of doxycycline (Sigma-Aldrich) during the 96 hours of the experiment to induce the 
expression of cDNA cloned in the pTRIPZ lentiviral doxycyclin-inducible vector. 
 
9. Statistical analysis 
 
Data were processed in Prism 6 (GraphPad software) using an unpaired, two-tailed Student’s 
t-test, or Mann–Whitney U test, as indicated.  
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Table M1: Antibodies used in this work 
 
 
 
 
 
 
 
Protein Species Source Use (dilution) Clone 
53BP1 Rabbit Novus Biological IF (1:500) Polyclonal 
CDKN1A/p21 Mouse BD Pharmingen IF (1:200) SX119 
CDKN1A/p21 Mouse Santa Cruz Biotechnology WB (1:200) F-5 
CDKN2A/p16Ink4a Rabbit Santa Cruz Biotechnology WB (1:1000 M-156 
H2A Rabbit Millipore WB (1:2000 Polyclonal 
H2AK119Ub1 Rabbit Cell Signaling WB (1:5000 D2754 
RING1A Rabbit (Schoorlemmer et al., 1997) WB (1:500)  
RING1B Rabbit (Garcia et al., 1999) 
IF (1:1000), 
WB 
(1:1000)  
BMI-1 Rabbit Cell Signaling WB (1:1000) D42B3 
RPA32 Rat Cell Signaling IF (1:100) 4E+04 
α-tubulin Mouse Sigma-Aldrich WB (1:50.000) B-5-1-2 
γH2AX (Ser139) Rabbit Cell Signaling IF (1:400) 20E3 
γH2AX (Ser139) Mouse Biolegend IF (1:400), WB (1:750) 2F3 
p53 Mouse Cell Signaling WB (1:1000) 1C12 
Phospho-p53 (ser15) Rabbit Cell Signaling WB (1:500) Polyclonal 
p57 Rabbit Santa Cruz Biotechnology WB (1:500) H-91 
Phospho-p38-MAPK Rabbit Cell Signaling WB (1:1000) Polyclonal 
p38-MAPK Rabbit Cell Signaling WB (1:1000) Polyclonal 
Phospho-AKT 
(Ser473/474/472) Rabbit GeneTex WB (1:200) Polyclonal 
p27 Rabbit Santa Cruz Biotechnology WB (1:300) C-19 
Active Caspase-3 Rabbit Promega IF (1:50) polyclonal 
Tuj-1 (β-tubulin III) Rabbit Covance 
IF (1:1000), 
WB 
(1:1000) 
MRB-435P 
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Table M2: qRT-PCR primers 
 
Gene (cDNA) Oligonucleotide Primer sequence 
β-actin sense GGCTTGTATTCCCCTCCATCG  
 antisence CCAGTTGGTAACAATGCCATGT  
NeuroD1 sense ATGACCAAATCATACAGCGAGAG 
 antisence TCTGCCTCGTGTTCCTCGT 
Eomes sense GGCCCCTATGGCTCAAATTCC 
 antisence CCTGCCCTGTTTGGTGATG 
 	 39	
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1. RING1B role in proliferation and viability of neural 
stem cells 
 
To gain insight into the mechanisms by which RING1B could be controlling neural stem cells 
(NSCs) proliferation and/or viability, we explored best readouts to determine whether major 
cell cycle regulators were involved in this process.  
 
1.1. Proliferation and apoptosis in RING1B-deficient neural stem 
cells 
 
We first quantified the effect of RING1B deletion in NSCs proliferation by culturing NSCs 
under conditions that allow neurospheres generation (Reynolds & Weiss, 1996). We then 
measured their diameters and total number of derived cells. RING1B deficiency induced a 
proliferative defect and, as a result, less and smaller neurospheres were obtained at day +4 after 
EtOH (Ring1Bf/f) or 4’-OHT (Ring1BΔ/Δ) treatment (Fig.R1A). Thus, RING1B-mutant 
neurospheres contained around half the cells than control and their diameters were also around 
half those of wild type spheres (Fig.R1B). 
 
We then aimed to determine if the decrease in cells number and neurospheres sizes was due to a 
proliferation defect or an increase of apoptosis. We first performed EdU incorporation assay. 
Similarly to BrdU, EdU (5-ethynyl-2’-deoxyuridine) is a nucleotide analog incorporated in 
replicative cells. At day +3 and +4 after EtOH and 4’-OHT treatment, we pulse-labeled 
Ring1Bf/f and Ring1BΔ/Δ monolayer cultures with EdU (10μM) for ten minutes (Fig.R1C). 
Immunofluorescence analysis showed that the percentage of cells that had incorporated EdU 
was significantly lower in RING1B-mutant than in control cells, 38 vs 28% or 25%, at days +3 
and +4 respectively. 
 
This was consistent with our already reported poorer expansion of RING1B-deficient, 
compared to wild-type neurosphere cultures at day+4 after EtOH/4’-OHT treatment (Román-
Trufero et al., 2009) 
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Figure R1. Impaired proliferation of RING1B-deficient neural stem cells. (A) 
Representative micrographs of neurospheres at day+4 after EtOH or 4’-OHT treatment 
(Ring1Bf/f and Ring1BΔ/Δ, respectively). (B) Left: total cell number in Ring1Bf/f and Ring1BΔ/Δ 
cultures (n=3). Right: scatter plot showing neurosphere diameters. At least 100 
neurospheres diameters were measured in each experiment (n=7). Red bar shows median 
value. (C) Cell proliferation rates (n=7) measured as percentage of EdU-positive cells (10 
minutes pulse labeling) at day +3 and day +4 after 4’-OHT addition, as assessed by 
immunofluorescence analysis. (D) Caspase-3 and Annexin V-staining labeling showed 
infrequent apoptosis signals in control and Ring1B mutant cells. At least 300 cells were 
analyzed in each experiment (n=3). Bar charts represent mean±s.d. (B left, C and D) and 
p values were calculated using unpaired, two-tailed Student’s t- (B left, C and D), or 
Mann–Whitney U (B, right) tests. Scale bar=200 microns (A), 50 microns (C). 
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Next we performed Annexin V and Caspase-3 immunostaining to test if reduced cell number 
and neurosphere sizes of mutant cells were associated with cell death due to increased apoptosis. 
Annexin V staining (Fig.R1D, right chart) was similar in both mutant and control cells: 5% and 
6% Annexin V+ cells respect to total cells in Ring1Bf/f and Ring1BΔ/Δ, respectively. In addition, 
caspase-3 analysis (Fig.R1D, left chart) also showed very similar labeling in mutant and control 
cells, with almost no apoptotic cells in either culture (0.8% and 0.6% of caspase-3+ cells respect 
to total cells in Ring1Bf/f and Ring1BΔ/Δ cultures, respectively).  
 
Collectively, these results show that defective expansion of RING1B-mutant NSCs is due to a 
decrease in the proliferative rate with no increase in apoptosis. It also allowed us to choose 
quantification of neurospheres diameters and EdU incorporation as main readout of RING1B 
deficiency-associated phenotype in NSC cultures. 
 
1.2. Cyclin-dependent kinase inhibitors expression in the 
absence of RING1B 
 
RING1 and other PcG proteins are responsible for Cdkn2a locus repression (Bracken et al., 
2007; Bruggeman et al., 2005; Calés et al., 2008; Jacobs et al., 1999; Maertens et al., 2009). 
Other Cdk inhibitors have also been associated with RING1B and Polycomb activity (Calés et 
al., 2008; Fasano et al., 2007; Pateras et al., 2009; Román-Trufero et al., 2009; Bravo et al. 
2015). We thus decided to look at the expression of some of these proliferation inhibitors.  
 
Figure R2. Cyclin-dependent kinases inhibitors protein levels in 
control and RING1B-mutant neural stem cells 
 Western blotting analysis of total protein extracts (20µg of protein/lane) of 
control (-4’-OHT, control) and mutant (+4’-OHT, KO) neurospheres. Alpha-
Tubulin was used as loading control. 
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We performed Western Blotting analysis with Ring1Bf/f and Ring1BΔ/Δ neurosphere cultures 
protein extracts. As expected, RING1B depletion induced p16-INK4a upregulation as already 
described in other cell types (Fig.R2). Equally, p57/CDKN1C and p21/CDKN1A were both 
upregulated whereas p27/CDKN1B levels seemed to be lower in RING1B-mutant than in 
control cultures.  
 
It can thus be hypothesized that proliferation defects in RING1B deficient NSCs may be due to 
increased cell cycle inhibitors. To determine whether all or only some of them was responsible 
for the antiproliferative phenotype we decided to first concentrate into p16-INK4a, as 
paradigmatic PcG target, and into p21/CDKN1A, recently shown to be upregulated after 
Ring1B inactivation in different cell types (Bravo et al., 2015; Koike et al., 2014).  
 
 
1.3. RING1B deficiency-driven proliferation defect and p16-
INK4a upregulation 
 
We first derived OBSCs from Ring1Bf/f, ER-Cre, Cdkn2a-/- 13.5 d.c.p. embryos and cultured them 
in the presence or absence of 4'-OHT. Western blotting analysis performed with neurospheres 
protein extracts  (day+4 after EtOH/4`-OHT treatment) to confirm Ring1B recombination in 
4'-OHT-treated extracts, as well as absence of p16-INK4a expression in Cdkn2a-/- cells. We also 
confirmed the increase of p16-INK4a levels in RING1B-mutant cells (Fig.R3A). Although no 
apparent increase in neurosphere size was detected (Fig.R3B), we measured their diameters as 
well as EdU incorporation to test proliferation ability of single or double mutant cells. The 
combined inactivation of Ring1B and of Cdkn2a resulted only in a modest, non-significant, effect 
on cell proliferation. Thus, the size of the neurospheres increased only marginally (Fig.R3C) and 
the proportion of double mutant cells that incorporated EdU was also augmented modestly 
(Fig.R3D). 
In any case, double mutant cells produced significantly smaller neurospheres compared to their 
control values, but not much different form RING1B-deficient cultures. 
 
We conclude that p16-INK4a does not play a crucial role in the early antiproliferative effect of 
RING1B loss. 
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Figure R3. Cdkn2a locus knock-out did not rescue the proliferative defect of 
RING1B-mutant cells. (A) Western Blotting showing RING1B and p16-INK4a 
expression in neurosphere extracts from Cdkn2a WT and KO mice, untreated or treated 
with 4’-hydroxytamoxifen to induce Ring1B recombination. (B) Representative 
photographs of cultured neurospheres. Scale bar=400 microns (C) Scatter plot (n=3) of 
neurospheres diameters showing that, in Cdkn2a-/- cultures, most RING1B-mutant spheres 
remained smaller in size compared with RING1B-expressing cultures. At least 100 
neurosphere diameters were analyzed in each experiment. Red bars show median values. 
(D) Proliferation rates (n=3) measured as % of EdU-positive cells (10 minutes pulse 
labeling), as assessed by immunofluorescence analysis of Ring1Bf/f or Ring1BΔ/Δ cells 
bearing a wild type or a mutant Cdkn2a allele. Bar charts show mean±s.d. p values were 
calculated using unpaired, two-tailed Student’s t- (D), or Mann–Whitney U (C) tests. 
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1.4. RING1B absence-induced p21/CDKN1A upregulation and 
NSCs proliferation inhibition. 
 
1.4.1. Knockdown of p21/Cdkn1a effect on Ring1B-mutant 
neurosphere size 
 
We asked whether p21/CDKN1A upregulation was responsible for proliferation inhibition in 
RING1B-deficient NSCs. We knocked down p21/Cdkn1a by lentiviral transduction of a small 
hairpin RNA (shRNA) or of an empty vector (EV-control) as a control.  The cells were then 
treated with EtOH or 4’-OHT to induce Ring1B recombination. After 4 days, we photographed 
neurospheres to measure diameters and we obtained a protein extract from the same 
neurospheres. Western blotting assay (Fig.R4A) showed a clear downregulation of 
p21/CDKN1A in p21 shRNA-transduced NSCs. RING1B-deficient neurospheres transduced 
with p21 shRNA presented similar sizes to control cells (Fig.R4B), and the calculated diameters 
(Fig.R4B, right) confirmed the rescue of RING1B-deficiency phenotype, suggesting a critical 
role of p21/CDKN1A in proliferation of mutant cells 
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1.4.2. p21/Cdkn1a knock-out interference with proliferation defect of 
Ring1B mutant neural stem cells 
 
 
We then decided to analyze NSCs primary cultures from embryos that combined the 
conditional Ring1B allele and a null allele for Cdkn1a, encoding p21/CDKN1A. Western blotting 
analysis showed the absence of p21 expression in p21/Cdkn1a knock-out NSCs and RING1B 
deletion at day+4 after EtOH/4’-OHT treatment (Fig.R5A). 
Figure R4. Proliferation defect in RING1B-deficient NSCs is 
mediated by p21/CDKN1A. (A) Western blot showing p21/CDKN1A 
levels in Ring1Bf/f (-4’-OHT) or Ring1BΔ/Δ (+4’-OHT) cells transduced with a 
lentivirus expressing p21 shRNA or an empty vector (EV-control). (B) Left: 
Representative photographs of Ring1Bf/f or Ring1BΔ/Δ neurosphere cultures, 
transduced with p21 shRNA or an empty vector (EV-control). Right: Scatter 
plot of neurospheres diameters showing that RING1B-mutant spheres 
transduced with p21 shRNA have a similar size compared with controls. At 
least 100 neurosphere diameters were analyzed in each experiment (n=3). 
Red bars show median values. Scale bar=400 microns (B). p values were 
calculated using unpaired Mann–Whitney U (B) tests; ns, not significant (P≥ 
0.05). 
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Ring1BΔ/Δ, Cdkn1a-/- culture displayed noticeable recovery of neurospheres size (Fig.R5B), further 
assessed by measuring their diameter (Fig.R5C).  
When Ring1Bf/f or Ring1BΔ/Δ, Cdkn1a-/- NSCs were pulse-labeled with EdU, they showed a similar 
proliferation rate respect to RING1B proficient cells (Fig.R5D) 
Figure R5. p21/Cdkn1a knock-out rescued the proliferative defect in 
RING1B-mutant neural stem cells. (A) Western blot showing RING1B and 
p21/CDKN1A levels in Ring1Bf/f (-4’-OHT) or Ring1BΔ/Δ (+4’-OHT) cells and 
absence of p21/CDKN1A in Cdkn1a-/- NSCs. Tubulin Alpha-1A chain was used as 
loading control. (B) Representative phase-contrast images of Ring1Bf/f or Ring1BΔ/Δ 
neurosphere cultures bearing a wild type (+/+) or a mutant (-/-) p21/Cdkn1a allele, 
at day+4 after 4’-OHT or EtOH treatment. Scale bar=400 microns. (C) Scatter 
plot of neurosphere diameters showing that Ring1BΔ/Δ, Cdkn1a-/- double mutant 
spheres have a similar size compared to controls. At least 100 neurosphere 
diameters were measured in each experiment (n=3). Red bars show median values. 
(D) Proliferation rates (n=3) measured as % of EdU-positive cells (10 minutes pulse 
labeling), as assessed by immunofluorescence analysis of Ring1Bf/f or Ring1BΔ/Δ cells 
bearing a wild type (+/+) or a mutant (-/-) Cdkn1a allele. Bar charts show 
mean±s.d. p values were calculated using unpaired, two-tailed Student’s t (D), or 
Mann–Whitney U (C) tests. ns, not significant (P≥ 0.05).  
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These results further demonstrate that the RING1B deficiency-driven proliferative defect is 
mediated by p21/CDKN1A levels increase.  
 
2. RING1B role in the response to DNA Damage  
 
It has been described that, on top of the well-known role in transcriptional silencing (Di Croce & 
Helin, 2013; Lanzuolo & Orlando, 2012; Simon & Kingston, 2009), H2AK119 ubiquitylation 
and localization of RING1B and BMI-1 at sites of DNA Damage might be related to DNA 
damage response (Chou et al., 2010; Ginjala et al., 2011; Ismail et al., 2010)  
 
We aimed at determining whether RING1B deficiency provoked DNA damage in NSCs, with 
no external sources of induced-DNA damage, UV or IR-laser treatment.  We checked for the 
presence of two very-well known DNA damage markers, phosphorylation of H2AX at Serine 
139 (hereafter γH2AX) and detection of 53BP1 at site of DNA damage (Balajee & Geard, 2004; 
Fernandez-Capetillo et al., 2004; Wang, Matsuoka, Carpenter, & Elledge, 2002). 
 
 
2.1. Phosphorylation of H2AX and presence of RPA foci in 
proliferating Ring1B-mutant neural stem cells 
 
 We first performed a Western Blotting analysis with control and mutant proliferating 
neurosphere protein extracts to determine phosphorylation of H2AX at serine 139. As shown in 
Fig.R6A, γH2AX levels increased in Ring1B mutant cells, compared to control cells. We then 
performed immunostaining analysis to determine the extent of DNA damage at single cell level. 
Co-immunostaining of γH2AX and EdU (Fig.R6B) allowed identification of γH2AX 
fluorescence intensity in non-proliferating (EdU-) and proliferating (EdU+) cells. As seen in 
Fig.R6C, γH2AX labeling was more intense in EdU+ cells respect to non-proliferating cells, and 
significantly increased in Ring1B mutant neural stem compared to control cells (p<0.0005). No 
differences were observed between Ring1B mutant and control non-proliferating (EdU-) cells. 
However, γH2AX foci appeared at higher frequencies in mutant than in control proliferating 
cells (Fig.R6C, panel right). From then on, we decided to score fluorescent intensity of γH2AX 
in EdU+ cells only.  
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The evidence of DNA damage only in proliferative mutant cells could be related to replicative 
stress. We decided to check for the presence of RPA32, a ssDNA-binding protein that protects 
DNA from the nuclease activity, and can be considered a replicative stress read-out (Zou & 
Elledge, 2003). To detect insoluble replication-associated RPA, EdU-pulsed cultures were 
treated with detergent, prior to fixation (Fig.R6D). We found almost a twofold increase of scored 
double EdU+/RPA32+cells with signs of replicative stress among mutant compared to control 
cultured cells (Fig.R6D, right charts). 
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Figure R6. DNA damage foci are detected in RING1B deficient NSC cultures. 
(A) Western blotting showing an increase of H2AX phosphorylation in mutant culture. H2A 
histone was used as loading control (B) Immunostaining of γH2AX, EdU and DAPI in 
Ring1Bf/f or Ring1BΔ/Δ neural stem cells monolayer cultures at day +4 after EtOH/4’-OHT 
treatment, showing presence of γH2Ax foci in proliferating (EdU+) RING1B-mutant cells. 
Scale bar=10 microns. (C) Left: Scatter plot of γH2AX fluorescence intensity in 
proliferating (EdU+), or non-proliferating (EdU-) cells, showing an increase of γH2AX signal 
in proliferating RING1B-mutant culture. Red bars show median values. Right: Relative 
frequency of γH2AX foci/EdU+ cells in control and RING1B-mutant neural stem cells. At 
least 100 EdU- and EdU+ cells were analyzed for each condition and experiments (n=3). (D) 
Left: Representative immunostaining of RPA32-/EdU+ and RPA32+/EdU+ NSCs. Cells 
were pre-extracted with detergent before fixation in order to detect insoluble RPA32 only. 
Scale bar=20 microns. Bar chart (right) indicates % of RPA+/EdU+ cells in Ring1Bf/f or 
Ring1BΔ/Δ cultures (n=2). p values were calculated using unpaired, two-tailed Student’s t-(D), 
or Mann–Whitney U test (C). ns, not significant (P≥ 0.05).  
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2.2. Accumulated double-strand breaks in RING1B-deficient cells 
 
To further assess the number of double-strand breaks foci, we aimed at determining 53BP1 foci, 
as it accumulates at site of double-strand breaks and plays an active role in DNA damage 
response and repair (Wang et al., 2002).  Immunostaining of 53BP1 and EdU showed that 
double-strand breaks foci accumulated in proliferating EdU+ cells (Fig.R7A), as observed for 
γH2AX. The percentage of 53BP1+/EdU+ cells (more than 3 foci per cell) was higher in Ring1B 
mutant than in control cells (3.9% vs 24.2%, p<0.0005) (Fig.R7B, left chart). 
 
 
 
Figure R7. 53BP1 double-strand breaks foci are detected in RING1B 
deficient NSC cultures. (A) Immunostaining of 53BP1, EdU and DAPI in 
Ring1Bf/f or Ring1BΔ/Δ neural stem cells monolayer cultures at day +4 after EtOH 
or 4’-OHT treatment, respectively, showing the presence of 53BP1 foci in 
proliferating (EdU+) RING1B-mutant cells. Scale bar=10 microns. (B) Left: 
percentage of 53BP1+/EdU- or 53BP1+EdU+ cells (3 or more foci/cell were 
considered as positive). At least 100 EdU- and EdU+ cells were analyzed for each 
condition and experiment (n=3). Bar charts show mean±s.d. Right: Relative 
frequency of 53BP1 foci/EdU+ cells in control and RING1B-mutant neural stem 
cells. p values were calculated using unpaired, two-tailed Student’s t-(B left), or 
Mann–Whitney U test (B right). ns, not significant (P≥ 0.05).  
Results 
53	
	
In addition, we scored 53BP1 foci at single cell level, analyzing proliferating cells (EdU+) only 
(Fig.R7B, right histogram). The relative frequency of 53BP1 foci in EdU+ cells appeared at 
higher frequencies in Ring1B mutant cells.  
These results indicate that RING1B is essential to assure that DNA damage does not 
accumulate in proliferating NSCs, thus may be essential to maintain genomic stability.  
 
 
3. RING1B and the ATM/ATR-P53 DNA damage 
checkpoints 
 
As DNA damage results in the activation of ATM, responsible for the phosphorylation of H2AX 
and of activating the p53/p21 checkpoint axis (Abraham, 2001; Shiloh & Ziv, 2013; Smith et 
al., 2010), we wanted to evaluate whether the upregulation of p21/CDKN1A in RING1B-
deficient cells was due to an activation of DNA Damage Response (DDR) through ATM and 
P53 activation.  
 
 
3.1. Tp53 knockout interference with proliferation defect of 
RING1B-deficient neural stem cells  
 
We first evaluated whether P53 was mediating RING1B deficiency effect on neurospheres 
proliferation. For this, we derived NSCs from mice bearing a wild type or a mutant Tp53 allele 
and the floxed Ring1B allele.  
 
Western Blotting analysis confirmed the absence of P53 and recombination of Ring1B (Fig.R8A). 
We could also observe that no significant changes in P53 expression were detected in the 
absence of RING1B in Tp53+/+ cells, whereas p21/CDKN1A levels increased, as already 
described for Ring1B mutant NSCs, probably due to P53 phosphorylation that results in its 
activation (Fig.R9A). However, p21/CDKN1A was undetectable in the absence of P53, 
regardless of the presence or absence of RING1B (Fig.R8A), indicating that, at least in these 
cells, p21/Cdkn1a expression is exclusively controlled by the transcriptional activity of P53.  
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In agreement to what had been observed in p21/Cdkn1a-/- NSCs, no differences in neurospheres 
size (Fig.R8B) or EdU incorporation (Fig.8C) were observed between RING1B control and 
mutant cells in Tp53 knock-out background.  
Thus, the absence of P53 completely rescued proliferation defects of Ring1B mutant NSCs by 
impeding p21/Cdkn1a expression, in a similar way that we observed in p21/Cdkn1a -/- cells or 
knocking-down p21/Cdkn1a. 
 
 
Figure R8. Tp53 knock-out rescued the proliferative defect in RING1B-
mutant neural stem cells (A) Western blotting assay performed with RIPA total 
protein extract showing absence of P53 and p21 expression in Ring1Bf/f or Ring1BΔ/Δ 
cells bearing a wild type (+/+) or a mutant (-/-) Tp53 allele. Tubulin Alpha-1A 
chain was used as loading control. (B) Scatter plot of neurospheres diameters 
showing that Ring1BΔ/Δ, Tp53-/- double mutant spheres have a similar size respect to 
controls. At least 100 neurospheres diameters were measured in each experiment 
(n=3). Red bars show median values. (C) Proliferation rates: % of EdU-positive cells 
after a pulse of 10 minutes at day +4 after addition of EtOH or 4’-OHT (n=3) of 
Ring1Bf/f or Ring1BΔ/Δ cells bearing a wild type (+/+) or a mutant (-/-) Tp53 allele. 
Bar charts show mean±s.d (n=3). p values were calculated using unpaired, two-
tailed Student’s t (C) or Mann–Whitney U (B) tests. ns, not significant (P≥ 0.05).  
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3.2. DNA damage and ATM/P53/p21 pathway activation in RING1B-
deficient NSCs  
 
 
It is known that DSB formation predominantly signals through Ataxia Telangiectasia Mutated 
(ATM) kinase which modifies a large number of substrates, including H2AX, P53, CHK2, 
NBS1, and BRCA1 (Abraham, 2001; Shiloh & Ziv, 2013; Smith et al., 2010). To determine if 
the p21-dependent proliferative arrest seen in RING1B-deficient NSCs was a consequence of 
ATM-DNA damage signaling activation, we used a commercial, specific and very potent small 
molecule inhibitor of ATM, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one, termed KU-
55933 (Hickson et al., 2004) to inhibit ATM kinase activity and to block the ATM-P53-p21 
pathway.  
 
We treated RING1B-deficient cells for two hours with 10μM of KU55933 (+ATMi), or DMSO 
as control (-ATMi). Western blotting analysis of Ring1B mutant NSCs exposed to ATM inhibitor 
showed a decrease in P53ser15 and H2AX phosphorylation (pP53 and γH2AX, respectively) 
together with the abrogation of p21/CDKN1A accumulation in mutant NSC (Fig.R9A). 
Control and Ring1B mutant cells were pulse-labeled with EdU just after ATM inhibitor 
treatment. A rescue of the proliferation rate could be observed in ATMi-treated RING1B-
depleted cells, showing comparable values of EdU incorporation than control cells (Fig.R9B). 
γH2AX and p21/CDKN1A expression was also evaluated in immunofluorescence assay that 
confirmed a decrease of γH2AX signal in EdU+ cells and of p21/CDKN1A labeling in mutant 
cells with an inhibited ATM (Fig.R9C and D). 
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Figure R9. DNA damage activated ATM-P53-p21 DNA damage response 
(DDR) in RING1B-deficient NSCs (A) Western blotting showing phosphorylation 
of P53 (Serine15), H2Ax and increase in p21 levels in mutant culture. Treatment with 
ATM inhibitor (ATMi, KU55933 10μM, 2 hours) reduced phosphorylation of P53 
and of H2Ax and levels of p21. Tubulin Alpha-1A chain was used as loading control 
(B) Proliferation rates: % of EdU-positive cells after a pulse of 10 minutes at day +4 
after addition of EtOH or 4’-OHT (n=3) of Ring1Bf/f or Ring1BΔ/Δ cells treated 
(ATMi), or not (-), with ATMi added just before EdU pulse. Bar charts show 
mean±s.d (n=3). (C) Left: Immunostaining of γH2AX in EdU+ nuclei of Ring1Bf/f 
and Ring1BΔ/Δ NSCs treated or not with ATMi. Right: Scatter plot of γH2AX 
fluorescent intensity of EdU+ cells treated, or not, with ATMi, showing a reduction of 
fluorescent intensity after ATMi treatment in mutant cells. (D) Left: Immunostaining 
of P21 of Ring1Bf/f and Ring1BΔ/Δ NSCs treated or not with ATMi. Right: Scatter plot 
of p21 fluorescent intensity in control or mutant cells treated, or not, with ATMi. 
Scale bar=10 microns (C and D). Red bars show median values (C and D). At least 
100 EdU+ cells were analyzed in each experiment (C and D, n=3). p values were 
calculated using unpaired, two-tailed Student’s t- (B), or Mann–Whitney U (C and D) 
tests. ns, not significant (P≥ 0.05). 
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3.3. ATR-dependent H2AX phosphorylation and RING1B-deficient 
NSCs proliferation 
 
 
H2AX and P53 are common substrates of ATM and ATR kinase activity (Abraham, 2001; 
Adams et al., 2010). We thus look for a possible ATR activation in response to replication stress. 
We used a specific ATR inhibitor (ETP-46464) (Toledo et al., 2011) to verify the possible 
activation of ATR-P53-p21 pathway. As shown in Fig.R10 (left plot), fluorescent intensity of 
γH2Ax was clearly reduced in Ring1BΔ/Δ, and also in control cells treated for two hours with the 
ETP-46464 (+ATRi) respect to DMSO (vehicle, -ATRi) treated cells. These data sustain a high 
basal level of γH2Ax in these cells due to ATR activity. Then we determined p21 levels in 
control and RING1B-deficient cells treated, or not, with ATRi. As shown in Fig.R10 (right 
plot), although to a lesser extent than without inhibiting ATR, p21 upregulation was still seen in 
mutant cells, suggesting a differential role of ATM and ATR in the DNA damage response in 
these cells. These results demonstrate that RING1B deficiency provokes DNA damage 
accumulation and subsequent DNA damage response involving ATM, P53 and p21 that results 
in a proliferative defect. 
 
 
Figure R10. ATR kinase affects H2AX phosphorylation but not p21 
expression (A) Scatter plot of γH2AX fluorescent intensity/EdU+ of Ring1Bf/f 
and Ring1BΔ/Δ NSCs treated, or not, with 10μM of ATR inhibitor (ATRi, ETP-
46464) showing a reduction of fluorescent intensity of γH2AX of RING1B-
deficient cells. (B) Scatter plot of p21 fluorescent intensity in control or mutant 
cells treated, or not, with ATRi. Red bars show median values. p values were 
calculated using unpaired Mann–Whitney U test. 
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4. RING1B and oxidative stress in neural stem cells 
 
DNA damage response occurs during normal proliferation due to replication stress provoked by 
various endogenous and exogenous factors. RING1A and RING1B-mediated ubiquitylation of 
H2A is essential to deal with replication of pericentric heterochromatin, a source of potential 
endogenous replication stress, at least in fibroblasts (Bravo et al., 2015).  
Among the sources of replication stress and DNA damage is the increase of reactive oxygen 
species (ROS) due to alterations of redox homeostasis mechanisms or external factors that 
facilitate their formation, such as ionizing radiations (i.e. UV exposure) or chemicals that 
increase the formation of free radicals (i.e carcinogens). (Ciccia & Elledge, 2010; Hoeijmakers, 
2009; RichardWagner, 2013) 
 
We asked whether RING1B could also be contributing to maintain a proper redox homeostasis 
to avoid a DNA damage response due to ROS-induced DNA damage 
 
 
 
4.1. RING1B and Reactive Oxygen Species (ROS) accumulation 
 
We asked if RING1B was related to ROS homeostasis that could contribute to set off DNA 
damage and DDR. We first analyzed accumulated ROS levels in control and Ring1B mutant 
NSCs using the cell permeant reagent 2’,7’–dichlorofluorescin diacetate (DCFDA), a 
fluorogenic dye that measures hydroxyl, peroxyl and other reactive oxygen species (ROS) 
activity within the cell. As shown in Fig.R11, absence of RING1B resulted in 1.6 fold increase 
levels of ROS. We used N-acetyl-cysteine (NAC), a ROS scavenger, to reduce ROS levels. 
Treatment with 0.5mM of NAC during 3 days significantly reduced ROS levels in RING1B-
deficient NSCs (Fig.R11, right charts). 
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These results indicate that ROS accumulate in the absence of RING1B. 
 
 
4.2. Oxidative stress-related DNA Damage in RING1B-deficient 
NSCs. 
 
One of the biggest hazards posed by oxidative stress is the generation of DNA damage and, in 
particular, DNA double-strand breaks (DSBs) (Hoeijmakers, 2009; Lombard et al., 2005) 
To determine if oxidative stress was the source of DNA damage accumulation in RING1B 
mutant NSCs we performed Western Blotting analysis to check phosphorylation of H2AX 
before and after treatment with antioxidant. The increase in γH2AX levels occurring in mutant 
cells was clearly reduced with antioxidant NAC treatment, with no changes in total H2A protein 
levels (Fig.R12A). Similarly, 53BP1 labeling at DSBs foci was dramatically reduced in NAC-
treated RING1B-deficient culture (Fig.R12B and C). Number of 53BP1 foci per cell and 
percentage of 53BP1+ cells (i.e., with more than 3 foci per cell) were restored to levels similar to 
control cells.  
 
Figure R11. ROS levels increase in the absence of RING1B. Left: 
Representative flow cytometry histogram of ROS levels as assessed by DCFDA 
fluorescence in control and RING1B-deficient neural stem/progenitor cells. Right: 
DCFDA fluorescence intensity quantified as fluorescence intensity of Ring1Bf/f and 
Ring1BΔ/Δ NSCs treated, or not, with N-acetyl-L-cysteine (NAC). Bar charts show 
mean±s.d (n=2) p values were calculated using unpaired, two-tailed Student’s t test  
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These results reinforce the idea that it is the accumulation of ROS that drive DNA damage in 
RING1B-deficient NSCs. 
 
 
 
 
Figure R12. Antioxidant treatment reduced DNA damage accumulation in 
RING1B-mutant NSCs. (A) Western blotting showing phosphorylation of H2AX. 
Treatment with NAC reduced phosphorylation of H2AX. H2A was used as loading 
control (B) Immunostaining of 53BP1 in EdU+ nuclei of Ring1Bf/f and Ring1BΔ/Δ NSCs 
treated, or not, with NAC. Scale bar=100 microns (C) Left: Box plot (5-95 percentile) 
of number of 53BP1 foci/EdU+ cell treated, or not, with NAC showing a reduction of 
DSBs (53BP1) in RING1B-deficient cells treated with NAC. Right: Bar charts 
showing the percentage of 53BP1 positive cells in mutant culture treated, or not, with 
antioxidant. Bar charts show mean±s.d (n=3). and red bars show median values. p 
values were calculated using unpaired, two-tailed Student’s t-test (C, right), or Mann–
Whitney U test (C, left). ns, not significant (P≥ 0.05).  
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4.3. Antioxidant treatment rescued proliferation defect of Ring1B 
mutant neural stem cells 
 
ROS-derived DSBs induces activation of ATM to active DNA repair, DNA damage response 
and cell cycle regulation. (Ditch & Paull, 2012; Z. Guo et al., 2010; Meter et al., 2016; Paull, 
2015)  
 
 To determine if presence of ROS was linked to DNA damage response and the subsequent 
proliferative defect observed in Ring1B mutant cells, we analyzed p21/CDKN1A fluorescent 
intensity in control and mutant cells treated (or not) with antioxidant for a period of 3 days. 
p21/CDKN1A expression was clearly reduced close to control levels (Fig.R13A). However, the 
increase in p16-INK4a levels that occurred as a consequence of RING1B deletion was still 
observed, despite NAC treatment of mutant cells (Fig.R13B). In these conditions of upregulation 
of p16-INK4a but normal levels of p21/CDKN1A the proliferative capacity of RING1B-
deficient NSC was not compromised in the presence of NAC. Thus, EdU-incorporating rates of 
NAC-treated mutant cells equaled to those of control cells (Fig.R13C) and cultured RING1B-
derived neurospheres achieved sizes comparable to control cells (Fig.R13D). 
 
This results point at the increased levels of ROS as the first cause of impaired proliferation in 
RING1B-deficient NSCs. 
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Figure R13. Proliferation of RING1B-deficient NSCs is restored with 
antioxidant treatment. (A) Scatter plot of p21/CDKN1A fluorescent intensity 
in control or mutant cells treated, or not, with NAC. (B) Western blotting 
showing that NAC treatment reduces p21/CDKN1A, but not the amount of p16-
INK4a, in mutant cells. (C) Proliferation rates: percentage of EdU-positive cells 
after a pulse of 10 minutes, 96 hours after addition of 4’-OHT (n=3) of Ring1Bf/f, 
Cre-ER cells treated, or not, with 0.5mM NAC for 4 days. Bar charts show 
mean±s.d.. (D) Scatter plot (n=3) of neurospheres diameters showing that 
Ring1BΔ/Δ spheres treated with antioxidants had a similar size respect to controls. 
Red bars show median values. p values were calculated using unpaired, two-tailed 
Student’s t-test (C), or Mann–Whitney U test (A and D). ns, not significant (P≥ 
0.05).  
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4.4. P38-MAPK pathway involvement in proliferation defect of 
RING1B-deficient neural stem cells 
 
p38-MAPK has been implicated in cell proliferation, differentiation, and survival of neural cells 
and is one of the signaling proteins induced in response to ROS (K. Sato, Hamanoue, & 
Takamatsu, 2008). We thus analyzed whether p38-MAPK would be an indirect manifestation of 
ROS accumulation in mutant cells. Western Blotting analysis showed no changes in p38-MAPK 
total levels, however its phosphorylated, active form increased in Ring1B mutant compared to 
normal cells. Such increase in p38-MAPK activation was clearly reduced by NAC treatment 
(Fig.R14A). 
We wondered whether p38-MAPK pathway would be involved in determining the inhibition of 
RING1B-deficient NSCs proliferation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure R14. P38-MAPK inhibition does not restore proliferation of 
RING1B-deficient NSCs (A) Western blotting showing phosphorylation of p38-
MAPK in mutant cells. Treatment with antioxidant reduced p38-MAPK 
phosphorylation (B) Scatter plot (n=3) of neurospheres diameters showing that 
RING1B-deficient spheres treated with p38 inhibitors were not able to restore 
proliferation. Red bars show median values. (C) Western blotting showing that p38 
inhibitor treatment did not reduce p21/CDKN1A levels in mutant cells. p values 
were calculated using unpaired Mann–Whitney U test (B). 
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We cultured Ring1Bf/f and Ring1BΔ/Δ neurospheres in the presence (+ p38i) or absence (-p38i) of 
SB203580, a selective inhibitor of p38-MAPK, previously described to improve  neurospheres 
numbers and proliferation rate in primary cultures from mouse embryonic brain (K. Sato et al., 
2008). Western blotting analysis performed with total protein extracts of neurosphere showed 
that p21 levels were still higher in Ring1BΔ/Δ cells respect Ring1Bf/f when treated with p38 
inhibitor (Fig.R14B, right blot). We then measured the neurospheres diameters but were unable 
to detect a rescue of proliferation in p38 inh.-treated RING1B-deficient NSCs (Fig.R14F). It 
thus seems that p38-MAPK kinase activity is not involved in the pathway leading to 
p21/CDKN1A upregulation and RING1B-deficient NSCs proliferation inhibition.  
 
Altogether, these results show that increased oxidative stress is at the basis of the effect of 
RING1B loss in NSCs proliferation, as a consequence of induced DNA damage and activated 
DNA damage response via ATM/P53/p21 pathway but independently of p38-MAPK 
signaling. 
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5. RING1B role in self-renewal/differentiation balance 
of neural stem cells and its relation to oxidative 
stress.  
 
Previous work in our laboratory had shown that inactivation of RING1B impaired proliferation 
and self-renewal and induced a premature differentiation toward neuronal (Román-Trufero et 
al., 2009). As shown up to this point, we had evidenced that RING1B was assuring NSCs 
proliferation through control of oxidative stress and of subsequent ATM/P53/p21 response to 
DNA damage, we asked whether these mechanisms were also at the base of RING1B control of 
NSCs self-renewal and differentiation. 
 
5.1. ROS influence(s) on RING1B-depleted NSCs 	
We wished to determine the possible contribution of the increased oxidative stress of mutant 
NSCs on its reduced self-renewal capacity (Román-Trufero et al., 2009). To this end we used a 
well-established clonal analysis assay in which self-renewal is assessed as the frequency of cells 
that are able to form a neurosphere from a single cell. Two types of experiments were carried 
out (Fig.R15A). In the first one, Ring1Bf/f  neurospheres received 4’-OHT or EtOH and the day 
after were dissociated into a single-cell suspension and seeded into 96-well plates. Duplicate 
cultures were set up with/without NAC. Wells that received a single cell were marked and 
followed during 10 days with daily additions of FGF-2 and EGF. In the second type of 
experiments (Fig.R15A), after 4'-OHT/EtOH treatment, cells received fresh medium and were 
let to grow neurospheres for four days. After desegregation into single cells, a clonal assay was 
performed as described above. 
 
At the end of day 10, 96-well cultures were photographed to measure the diameter of 
neurospheres and wells containing neurospheres larger than 40µm scored as cultures derived 
from a self-renewing single cells. Panels B and C of figure R15 evidence how the addition of 
NAC rescues the size of primary mutant neurospheres and the frequency of cells with 
clonogenic capacity, both of which were reduced, compared to controls, after RING1B-
depletion. Recovery, however, was far from total, although the differences did not score as 
statistically significant. On the contrary, mutant cultures seeded with cells grown for four days 
after RING1B-deletion, showed neurospheres of a severely diminished diameter whether in the 
absence/presence of NAC (Fig. R15E, left). In agreement with impaired proliferation that  
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resulted in small neurospheres, the proportion of wells containing single-cell derived 
neurospheres was also very much reduced (Fig.15E, right).  
The results of both types of experiments then appear as contradictory. In the first case, cells 
seeded while reducing their levels of RING1B, if their levels of ROS are maintained in check 
with NAC acted almost as cells that express RING1B. In the second type of experiment, 
cultures rid of most cells containing any RING1B act as if few of them initiate clonal cultures 
but the small neurospheres soon arrest growth. The results, at a first glance, appear 
contradictory because NAC-quenching of ROS in single cells seeded at the beginning of 
RING1B depletion has an effect not seen with single cells already lacking RING1B. In other 
words, in the latter case, proliferation arrest may be taking place by other mechanisms than 
those induced by oxidative stress.  
 
In summary, prevention of DNA-damage triggered breaks on proliferation of mutant cells can 
maintain their self-renewal capacity but only transiently.  
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Figure R15. Transient rescue of decreased self-renewal of RING1B-deficient NSCs by 
antioxidant treatment. (A):Schematic diagram of clonal analysis protocols to obtain primary and 
secondary Ring1BΔ/Δ spheres. In the first protocol (upper), 4-hydroxy-tamoxifen (4HT) was added to the 
cultures 18 hours before plating single cells and sphere formation was scored after 9 days in culture in 
presence/absence of NAC (+/-NAC). In the second protocol (bottom), 4HT was added at the time of 
plating cells at a density of 5,000 cells/cm2, to allow the formation of Ring1BΔ/Δ primary spheres growth in 
presence or absence of NAC (+/-NAC) for 4 days. At this point, mutant spheres cultured in presence of 
NAC displayed a restored proliferation as showed in fig. R13D. Then, primary spheres were disaggregated 
and plated as single cells in presence/absence of NAC. Ring1BΔ/Δ secondary sphere formation was also 
scored after 9 days in culture. (B and D): Phase-contrast images of representative primary (B) and 
secondary (D) single cell-derived neurospheres, at day+9 after cell seeding. Scale bar= 500 microns. (C 
and E): Left: Scatter plot of primary (C) and secondary (E) neurospheres diameters showing that NAC 
treatment significantly rescued primary Ring1BΔ/Δ spheres diameters (measure of proliferation) (n=2), but 
not rescue secondary Ring1BΔ/Δ neurosphere proliferation (n=2).  Right: Relative values (% of respective 
control) of single cells forming primary (C) or secondary (E) spheres. Antioxidant treatment increased self-
renewal ability of primary Ring1B mutant cells. Bar charts (C and E, right) show mean±s.d.. Red bars (C 
and E, left) show median values. p values were calculated using unpaired, two-tailed Student’s t- (C and E, 
right), or Mann–Whitney U test (C and E, left) tests. ns, not significant (P≥ 0.05). 
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5.2. ROS-independent differentiation of Ring1B-mutant NSCs 	
We also tested whether premature, unscheduled neural differentiation of NSCs associated to the 
loss of RING1B (Román-Trufero et al., 2009) was  influenced by ROS accumulation. We chose 
a couple of loci encoding two transcription factors involved in neurogenesis and neural identity, 
Eomes and NeuroD1, respectively, known to be derepressed in the absence of RING1B (Arnold 
et al., 2008; Boutin et al., 2010; Román-Trufero et al., 2009). Expression analysis, through Real 
time PCR of cDNAs derived from control and mutant cultures, grown with/without NAC 
during four days after beginning of inactivation, showed that derepression occurred to a similar 
extent for both of them (Fig. R16A). Thus, activation of differentiation program(s) in mutant 
cells seems independent of the concurrent accumulation of ROS. Further confirmation of this 
notion was the detection, in mutant cultures, of a neuronal-specific component of cytoskeleton 
(tubulin beta III) recognised by Tuj1 antibody. Figure R16B shows increased frequencies of 
Tuj1 +ve cells in mutant cultures, compared to controls, whether NAC is or not present in the 
medium.  
 
We conclude that the altered balance of ROS in RING1B-deficient cells does not stimulate or 
slow down, within the period studied, the associated neuronal differentiation. 
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Figure R16. RING1B inhibited premature differentiation of neural stem 
cells independently of ROS. (A) qRT-PCR analysis for Eomes and NeuroD1. 
Changes in expression levels are displayed as the ratio between normalized (for β-actin 
expression) levels of select transcripts in RING1B-deficient and wild-type neurosphere 
cultures cultured with (+NAC) or without (-NAC) antioxidant. (B) Left: 
Immunostaining of neuronal differentiation marker Tuj-1 and DAPI in control and 
mutant neural stem cells grown in the presence of mitogens, treated, or not (-), with 
NAC. Scale bar=100 microns. Right: quantification (bottom, n=3) of Tuj-1+ cells 
showing only partial decrease of neuronal differentiated (Tuj-1+) mutant cells when 
cultured in presence of NAC. Bar charts show mean±s.d. Western blotting showing as 
antioxidant treatment does not impede differentiation of mutant cells p values were 
calculated using unpaired, two-tailed Student’s t. ns, not significant (p>0.05). 
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6. BMI-1 stability is compromised in RING1B-
deficient cells 	
 
As shown above, RING1B deficiency resulted in accumulated ROS levels and activation of 
DDR mainly via ATM/P53/p21 axis. BMI-1, another component of PRC1 complex and 
cofactor of RING1B E3 ligase activity, plays a crucial role in regulating cell cycle entry and self-
renewal capacity, and has been described to control redox homeostasis and DNA damage repair 
in different cell types (Chatoo et al., 2009; Liu et al., 2009; Vissers Joseph H. A., 2012). 
 
We asked whether these functions described for BMI-1 were related to those we had seen in 
NSCs as a result of RING1B loss.    
 
We performed Western Blotting analysis to determine BMI-1 expression in NSCs. Surprisingly, 
BMI-1 was considerably downregulated in Ring1B mutant NSCs (Fig.R17A). However, 
RING1B paralog RING1A was upregulated. This indicated that RING1A was only able to 
partially compensate the effect of RING1B loss on BMI-1 levels.  
To determine if this RING1B-elicited regulation of BMI-1 levels was cell-type specific or a more 
general phenotype, we performed similar analysis with mouse embryonic fibroblasts (mEFs) 
derived from the same floxed-RING1B; creERT mouse model from which we derived NSCs. 
Although to a lesser extent than in NSCs, BMI-1 was also downregulated in Ring1BΔ/Δ mEFs, 
and RING1A levels were higher than in control fibroblasts (Fig.R17A, right). This suggested 
that RING1B plays a role in the homeostasis not only of its paralog, but also of its cofactor. 
Moreover, this effect on BMI-1 levels seems RING1B specific, since RING1A knock-out did not 
determine BMI-1 downregulation, but on the contrary, resulted in a robust increase of its levels 
(Fig.R17A, right blots). However, similarly as RING1A levels increased in the absence of 
RING1B, RING1B levels increased in the absence of RING1A (Fig.R17A, right blot), 
suggesting a reciprocal, compensating effect on each other paralog, but a distinct, opposite effect 
on their cofactor accumulation, i.e. on BMI-1 bulk. 
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Figure R17. RING1B assures BMI-1 stability. (A) Western blotting analysis performed 
with neural stem cells (left, NSCs) or mouse embryonic fibroblasts (right, mEFs) with the 
indicated genotypes. (B) Western blotting of mEFs transduced with a doxycyclin-inducible 
lentiviral vector expressing a WT (RING1B-WT) or a E3 ligase mutant (RING1B-E3-mutant) 
performed at day+4 after treatment with EtOH/4’-OHT. Exogenous (Exog.) or endogenous 
(Endog.) forms of RING1B are indicated. (C) Left: Proliferation rates: % of EdU-positive cells 
after a pulse of 30 minutes at 96 hours after addition of 4’-OHT (n=2) of RING1B, BMI-1 or 
RING1A-deficient mEFs compared to Ring1Bf/f as control. Right: ROS levels assessed by 
DCFDA fluorescence in control and RING1B, BMI-1 or RING1A-deficient mEFs. Bar charts 
show mean±s.d.. p values were calculated using unpaired, two-tailed Student’s t-test. (D) 
Western blotting analysis performed with control and RING1B-mutant neurospheres extracts, 
treated (+NAC), or not (-), with antioxidant. In Western blotting analysis, alpha-tubulin was 
used as loading control. 
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It would be possible that RING1B and BMI-1 also exerted reciprocal and specific effect on each 
other levels. We thus analyzed BMI-1 constitutively knocked-out mEFs. BMI-1 absence 
significantly affected RING1A, but only marginally RING1B levels (Fig.R17A, right), 
reinforcing the idea of RING1B specific control over BMI-1.  
 
To determine if this effect was directly related to RING1B function ubiquitylating H2A, we 
reintroduced a wild type or an E3 ligase mutant form of RING1B by means of doxycycline-
inducible lentiviral transduction. As shown in Fig.R17B, doxycycline treatment clearly induced 
the expression of RING1B-WT or RING1B-E3 mutant in transduced mEFs and compensated 
for endogenous RING1B protein loss after 4’-OHT treatment. Both WT or E3-mutant 
RING1B were able to stabilize BMI-1 and restore RING1A to control levels, indicating that 
BMI-1 and RING1A homeostasis are directly controlled by RING1B, independently of its E3-
ligase activity.  
 
To understand if RING1B loss affected proliferation and/or oxidative stress response in mEFs, 
as seen in NSCs, we performed EdU-incorporation assay and DCFDA (ROS)-analysis. We also 
analyzed mEFs derived from Bmi-1 and Ring1A KO embryos. As can be seen in Fig.R17C (left 
bar chart), Ring1BΔ/Δ, and also Bmi-1-/-, but not Ring1A-/- mEFs displayed a proliferation defect. 
However, only a modest increase in ROS levels was found after RING1B or RING1A loss (1.5-
fold increase), whereas BMI-1 loss increased ROS up to 3-fold compared to control mEFs 
(Fig.R17C, right). This suggests a principal role of BMI-1 in redox homeostasis and that 
RING1B depletion-elicited phenotype might be due to BMI-1 downregulation, that even 
increased RING1A levels cannot counterbalance. The data also imply the crucial importance of 
RING1B integrity to assure BMI-1 pool. 
   
In NSCs, it has been proposed that BMI-1 protein levels decrease could be a consequence of 
oxidative stress through activation of p38 MAPK pathway and AKT inhibition, with subsequent 
degradation of BMI-1 (Kim & Wong, 2009). We wondered if BMI-1 degradation observed in 
RING1B-deficient NSCs could be related to the presence of higher levels of ROS, and not the 
other way round as above hypothesized. Treatment with NAC (that rescued proliferation defect 
and DNA damage in Ring1B deficient NSCs) did not restore BMI-1 levels (Fig.R17D), despite 
the fact that AKT remained active, as indicated by maintained levels of phosphorylated, p-
AKT. Altogether, the results show that BMI-1 stability is strictly dependent on the presence of 
RING1B in both NSCs and mEFs, probably to assure an efficient response to oxidative stress.  
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6.1. Partial rescue of RING1B-deficient NSCs proliferation defect by 
overexpression of BMI-1 
 
To determine if the phenotype observed after RING1B loss in NSCs was due, at least in part, to 
BMI-1 degradation, we transduced NSCs with a doxycycline-inducible lentiviral vector to  
Figure R18. Overexpression of BMI-1 in RING1B-mutant neural stem cells 
partially rescued proliferation defect. (A) Western blotting analysis performed 
with neural stem cells transduced with a doxycycline-inducible lentiviral vector 
expressing BMI-1 (-/+ Dox) and selected with puromycin treatment for 4 days. RIPA 
protein extracts were performed at day +4 after EtOH/4’-OHT treatment to induced 
Ring1B recombination. (B) Representative photographs of Ring1Bf/f or Ring1BΔ/Δ 
neurosphere cultures transduced with doxycycline-inducible lentiviral vector expressing 
BMI-1, cultured in presence (+) or not (-) of doxycycline, Right: Scatter plot of 
neurospheres diameters showing that BMI-1 overexpression (+Dox) partially restore 
RING1B-mutant neurospheres diameters. At least 200 neurosphere diameters were 
analyzed in each experiment (n=2). Red bars show median values. Scale bar=400 
microns. (C) Proliferation rates: percentage of EdU-positive cells after a pulse of 10 
minutes, 96 hours after addition of EtOH/4’-OHT (n=2) of monolayer cultures 
previously transduced with doxycycline-inducible lentiviral vector expressing BMI-1 (-
/+ Dox). Bar charts show mean±s.d... (D) Scatter plot of p21 fluorescent intensity in 
control or mutant cells previously transduced with doxycycline-inducible lentiviral 
vector expressing BMI-1 (-/+ Dox). p values were calculated using unpaired, two-tailed 
Student’s t-test (C), or Mann–Whitney U test (D).  
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express BMI-1 (gain-of-function assay). We found that exogenous BMI-1 stability was 
compromised in RING1B-deficient NSCs to a similar extent as the endogenous protein 
(Fig.R18A). However, BMI-1 levels increased in both Ring1Bf/f and Ring1BΔ/Δ cells cultured in 
the presence of doxycycline almost twice as, much endogenous levels in untreated control and 
mutant cells. As expected, H2AK119ub levels increased after BMI-1 over-expression and 
RING1A levels were comparable to those in control cells. We observed a modest, but only 
partial, recovery of proliferation measured as neurospheres diameters (Fig.R18B) and EdU-
incorporation (Fig.R18D). Nonetheless, a statistically significant difference was still present 
between Ring1Bf/f and Ring1BΔ/Δ NSCs, despite BMI-1 over-expression. As could be expected 
according to impaired proliferation, p21/CDKN1A levels remained higher in Ring1B mutant 
cells also even though BMI-1 amount was partially recovered (Fig.R18C).  
 
Altogether, the data suggest that RING1B assures, at least in part, redox homeostasis and 
proliferation of NSCs by stabilizing its co-factor BMI-1. 
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In this work we find that the major cause of proliferation arrest of RING1B-depleted NSCs is 
caused by a DNA damage response, in turn triggered by an accumulation of ROS products. 
The proposed chain of events, leading to proliferation arrest in RING1B-deficient NSCs, 
starts with an imbalance of ROS products, a condition favorable to DNA damage, enhanced 
perhaps by defective repair in the absence of RING1B, which triggers the well known ATM-
P53-p21/CDKN1A pathway activated under stress conditions. Considering the possible 
involvement of BMI-1 in the regulation of ROS homeostasis in NSCs, RING1B function in 
ROS homeostasis appears inexorably linked to that of BMI-1 because of its destabilization in 
the absence of RING1B. Differentiation towards a neuronal pathway associated to RING1B 
depletion, however, is independent of RING1B-dependent proliferation status. Thus, levels 
of heterodimeric E3 ligase RING1-BMI-1 are critical to prevent DNA damage hindering 
NSCs expansion. In this function RING1B appears in a dominant position within its 
epistatic relationship with BMI-1. 
 
 
1. RING1B role in proliferation, an indirect 
consequence of the activation of ATM/P53/p21 
DNA damage response pathway.  
 
 
Our experiments show that P21/CDKN1A, but not p16-INK4a, is the main CDKI that 
mediates the proliferative defect of RING1B-deficient NSCs. KO of Cdkn2a/Ink4a, a well-
known Polycomb target locus, (Bracken et al., 2007; Calés et al., 2008; Jacobs et al., 1999; 
Maertens et al., 2009) is insufficient to rescue the proliferation defect in RING1B-deficient 
NSCs. This p16-INK4a-independent RING1B function is reminiscent of what happens in 
other settings, e.g lethality of RING1B-deficient embryos not rescued in Cdkn2a/Ink4a KO 
mice (Voncken et al., 2003) or the cooperation between mutations in Ring1B and 
Cdkn2a/Ink4a in myeloid progenitors expansion (Calés et al., 2008). 
 
Upregulation of CDK inhibitor p21/CDKN1A, concomitant to RING1B inactivation, had 
been observed by us and others in different cell systems (Bravo et al., 2015; Koike et al., 
2014). Knockdown of Bmi-1 also induces p21/CDKN1A upregulation in NSCs  
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(Fasano et al., 2007) thus indicating a clear relationship between RING1B/BMI-1 and 
p21/CDKN1A. Such a correspondence, however, is incomplete because in our cultures of 
Ring1B KO NSCs we have not detected the increased apoptotic rates associated to NSCs 
Bmi-1 knock down (Fasano et al., 2007). Upregulation of p21/CDKN1A could be 
interpreted as the consequence of the removal of a transcriptional repression exerted by 
PRC1. However, chromatin immunoprecipitation experiments from our lab did not show 
RING1B association to p21/Cdkn1a promoter proximal regions (Román-Trufero et al., 
2009), making difficult to sustain a repressive function being relieved in the absence of 
RING1B. Instead, we found that it is the activation of P53, a quintessential positive regulator 
of p21/Cdkn1a the influence responsible for its upregulation. In agreement with this, other 
targets of P53 (Trp53inp, Bid) were also found upregulated in RING1B-deficient NSCs 
(Román-Trufero et al., 2009), 
 
P53 activation, in turn, is the consequence of NSCs cells triggering DDR. Following 
RING1B deficiency, foci of phosphorylated of histone H2AX and 53BP1, two well 
established markers of of DSBs (Balajee & Geard, 2004; Wang et al., 2002)) accumulate in 
mutant cells. These changes at places of DSB, activate a complex pathway for DNA repair 
and, as stated above, relay on the activation of ATM kinase, which among its many 
substrates (S139 of H2AX phosphorylation only one of them) has P53, again one of the steps 
leading to its activation as transcriptional regulator (Lakin & Jackson, 1999; Maréchal & 
Zou, 2013; Sulli, Di Micco, & di Fagagna, 2012) 
 
Indeed, inhibition of ATM activity (ATM inhibitor treatment) in mutant NSCs blocks, P53 
and H2AX phosphorylation, p21/CDKN1A decreases to basal levels and proliferation arrest 
of RING1B-deficient NSCs does not occur. The results are coherent with the rescue of 
proliferation arrest of mutant NSCs bearing null alleles of p21/Cdkn1a or Tp53 genes. The 
close relationship between p21/CDKN1A and P53 in stressed NSCs is clear and had already 
been shown with irradiated NSCs which, if deficient in P53, cannot express p21/CDKN1A 
(Armesilla-Diaz et al., 2009). Altogether, we believe that proliferation arrest, a quick response 
to RING1B depletion, is the consequence of a DDR-related pathway which does not involve 
possible functions in transcriptional repression, at later stages in a senescent state, of genes 
encoding other cell cycle regulators may be derepressed. 
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1.1. Is DDR impaired in the absence of RING1B? 		
Increased signs of DNA damage (γH2AX and 53BP1 foci, marking DSBs) in RING1B-
deficient NSCs relates clearly to oxidative stress. However, the persistence of DSBs foci may 
also be a signal of impairment of DNA repair functions. This may come as no surprise given 
the large body of evidence implying both RING1B and BMI-1 in the repair of irradiation-
induced DNA breaks (Bergink et al., 2006; Ginjala et al., 2011; H. Ismail et al., 2010; Pan, et 
al., 2011; Vissers Joseph H. A., 2012). A difference, though, is that in our system DNA 
damage arises spontaneously, without exogenous perturbation. DNA damage related to 
oxidative stress is thought to derive from replication of DNA structures altered by oxidation 
leading, perhaps, to replication blocks (Burhans & Weinberger, 2007; Lindahl, 1993; 
Woodbine et al., 2011). Our data fit this interpretation as the accumulation of DSB foci 
correlates with the ability of mutant cells to incorporate EdU. At this stage, DNA damage 
secondary to oxidative stress would be equivalent to the breaks induced upon irradiation, a 
situation in which contributions of RING1B and BMI-1 have been probed necessary 
((Ginjala et al., 2011; Ismail et al., 2010; Pan et al., 2011; Ui et al., 2015). The participation 
of Polycomb E3 ligases in DSB repair using its activity to monoubiquitylate histones H2A 
and H2AX has been inferred from radiation-induced DNA breaks, many of which would 
take place on G1, i.e. non replicating cells (Ginjala et al., 2011; I. H. Ismail et al., 2012). It 
could be assumed that histone H2A modifications may also be required for DSB appearing 
during S-phase and therefore, the very low E3 ligase activity of mutant cells, despite their 
increased levels in RING1A, would imply that a similar DNA repair functionality is missing 
in RING1B-deficient NSCs. This in an assumption ease to subject to experimental test by 
ectopic expression of a E3 ligase inert form of RING1B.   
 
 
1.2. RING1B management of oxidative stress 	
 
Why loss of RING1B could end up in DNA damage? We and others have appreciated a 
function of RING1B (particularly together with RING1A) during DNA replication (Bravo et 
al., 2015; Piunti et al., 2014), preventing fork stalling and associated accumulation of DSB. 
We have not attempted to get direct evidence of replicative stress on DNA fibers (molecular 
combing experiments) on the basis that such a replication defect is associated to the 
combined inactivation of both RING1A and RING1B and, therefore, we consider it a less 
likely possibility. The possibility of an alternative source of DNA damage, that triggered by  
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an accumulation of ROS was not as clear as it might have appeared from initial reports on 
Bmi-1 KO-hematopoietic cells. Instead, in NSCs and neurons oxidative stress occurs both 
under gain-of and loss-of BMI-1 function (Acquati et al., 2013; Chatoo et al., 2009). 
Oxidative stress comes as an imbalance between ROS and cellular anti-oxidant defenses 
(Lombard et al., 2005)). ROS can cause lipid peroxidation, protein damage, and several 
types of DNA lesions: single- and double-strand breaks, adducts (as 8-oxoguanine (8-oxoG)) 
and cross-links (Lindahl, 1993; RichardWagner, 2013). SSBs or DSBs normally are thought 
to occur arise when replicative (and also transcription) machinery encounters endogenous 
ROS-induced lesions (Burhans & Weinberger, 2007; Lindahl, 1993; Woodbine et al., 2011). 
 
Our observation of increased ROS products in Ring1B-mutant NSCs, however, suggested 
that, after all, it was possible that as a consequence of their accumulation some DNA damage 
might occur. Indeed, the addition of a ROS scavenger, such as NAC to the cultures, 
prevented the development of DSB foci and proliferation arrest, thus linking alterations in 
ROS homeostasis with proliferation status in NSCs depleted of RING1B.  However, when 
considering the anti-proliferative consequences of ROS accumulation, we stand on our 
conclusion that the major player involved is p21/CDK21A, despite precedents linking p16-
INK4a  upregulation  to ROS-induced  activation of p38-MAPK. Reports on hematopoietic 
and skin cells showed a clear antiproliferative response associated to increased ROS (Jenkins 
et al., 2011; K. Sato et al., 2008; Shao et al., 2011) but in our system p38-MAPK inhibition 
failed to rescue RING1B-induced senescence. 
 
How RING1B may participate in ROS homeostasis is not clear. A very first idea, that the 
expression of genes encoding anti-oxidant products was affected was ruled out from our 
analysis showing no evidence of altered levels of mRNAs encoding products with a role in 
ROS homeostasis (Román-Trufero et al., 2009). Although loss-of-BMI-1 function in NSCs 
also failed to show alterations in these mRNAs (Fasano et al., 2007), of known this contrasts 
with deregulation of some of these products in Bmi-1 KO neurons and thymocytes ((Chatoo 
et al., 2009; Liu et al., 2009)). In this regard, our Bmi-1 KO mEFs also showed ROS 
accumulation. 
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2. RING1B-BMI-1 stabilization 		
The inability of RING1A to substitute for RING1B and act as an E3 ligase in mutant NSCs 
could be due to the downregulation of BMI-1. In vitro, RING1B and RING1A show E3 
ligase activity on nucleosomal substrates upon heterodimerization with any of the members 
of the PCGF family (Taherbhoy et al., 2015). Therefore it could have been expected that any 
of the other of the PCGF members in NSCs could substitute for BMI-1. However, proteomic 
analysis of neural progenitors suggest that it is BMI-1 the major PCGF that associates to 
RING1B (Kloet et al., 2016) perhaps because either levels of other PCGFs are low or their 
hypothetical association to RING1A in vivo differs from what is observed in vitro. One way 
or another we determined that the outcome is one in which global levels of H2AUb are very 
low in Ring1B mutant NSCs. 
 
Downregulation of BMI-1 in the absence of RING1B is also seen in ES cells ((Leeb & Wutz, 
2007)) and at a much lower extent in mEFs. It is possible then that the mechanisms involved 
in the positive regulation of BMI-1 by RING1B are cell type-specific. In NSCs, at least, such 
mechanism(s) are unrelated to transcriptional control because decreased protein level is not 
accompanied by a reduction in BMI-1 mRNA (Román-Trufero et al., 2009).  It is likely that 
events related to ubiquitylation of BMI-1, by other protein ligases than RING1B are 
involved (Ben-Saadon et al, 2006) and that RING1B, perhaps by forming a complex with 
BMI-1 interferes with such a destructive modification. Another example of PCGF 
stabilization by RING1B was seen in the co-transfection of plasmids expressing PCGF1 
together with increasing amounts of a plasmid expressing RING1B (Sánchez et al., 2007). 
Whether a reciprocal effect, that the PCGF partner, i.e. BMI-1 has a positive effect on 
RING1B (or RING1A) stability is another possibility implied by the notion of a reinforced 
steadiness linked to their association. In agree with this, we observed a partial decrease of 
RING1B, and clear downregulation of RING1A, in Bmi-1 KO mEFs.  
 
An alternative possibility to regulate Polycomb RING finger proteins is through the activity 
of deubiquitinases such as USP7 (Maertens et al., 2010). USP7 associates with RING1B-
containing complexes (Sánchez et al., 2007) and binds directly to BMI-1 (and MEL18) 
(Maertens et al., 2010). It is not clear how the regulatory hierarchy is, whether USP7 
function can take place independently of RING1B or not. If a direct contact with BMI-1 
would be everything that was necessary for its USP7-dependent stabilization then it might 
not be affected by RING1B depletion. However, being parallel, the depletion of both 
RING1B and BMI-1 in Ring1B-/- NSCs, it would appear more likely that perhaps the USP7- 
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BMI-1 contact was dependent on the heterodimer (with RING1B) and that not being in 
place, UPS7 fails to deubiquitylate BMI-1. 
 
 
3. In NSCs, RING1B independently regulates self-
renewal/differentiation balance and 
proliferation. 
 
NSCs proliferate while maintaining their undifferentiated state thanks to signaling pathways 
that mediate the actions of growth factors FGF and EGF. The transcriptional program 
responsible for the maintenance of this cell state depends, in part, of chromatin regulators 
such as Polycomb RING1B. Following its inactivation, NSCs become conducive to 
senescence and neuronal differentiation which together lead to severe loss of its original self-
renewal capacity. Thus, in RING1B-depleted NSCs, a possible link between ROS-induced 
DNA-damage, subsequent proliferative arrest, self-renewal loss and differentiation could be 
established. In fact, in other cell types such as skin or hematopoietic cells, the relationship 
between differentiation and DNA damage is clear (Santos et al., 2014; Sherman et al., 2011; 
Tedeschi & Di Giovanni, 2009). However, our data indicate that such links are rather cell 
type/context-specific, because neuronal differentiation, in our system, can be uncoupled 
from the DNA-damage response triggered by ROS accumulation. The manipulation of 
ROS levels in our system, using NAC, leads to an amelioration of the symptoms of self-
renewal but once differentiation is set in motion it seems clear that no remedy related to 
ROS will prevent self-renewal capacity from being lost in the absence of RING1B.  
Thus, although proliferation arrest can only imply self-renewal loss (certainly, not renewing 
in the absence of proliferation) the truly underlying cause appears more a consequence of 
ROS-independent differentiation.  
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As a way of summary, the cartoon in Fig.D1 shows a simplified representation of pathways 
regulated by RING1B (and BMI-1) in NSCs with an emphasis in proliferation control and 
the effects of the DDR activated by oxidative stress when cells are depleted of RING1B. 
 
 
 
 
 
 
 
 
  
Figure D1. The model highlights pathways regulated by 
RING1B (and BMI-1) in NSCs 
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Conclusions 
 
 
1) RING1B deficiency induces a drastic proliferation defect in neural stem cells 
mediated by upregulation of cell cycle inhibitor p21/CDKN1A 
 
2) Loss of RING1B results in an accumulation of endogenous DSBs that 
activate a DNA damage response (DDR) involving ATM activation, P53 
phosphorylation and p21/CDKN1A upregulation  
 
3) RING1B participates in redox homeostasis. High levels of ROS damage 
DNA and activate DDR in RING1B-deficient neural stem cells 
 
4) RING1B role in self-renewal and differentiation balance is independent from 
proliferation and cell cycle progression 
 
5) RING1B assures BMI-1 stability in neural stem cells. In mEFs, RING1B 
stabilizing effect on BMI-1 is independent of the E3 ligase activity.  
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Conclusiones 	
 
 
1) La ausencia de RING1B produce un drástico arresto proliferativo como 
consecuencia de una upregulación de p21/CDKN1A en células madres 
neurales 
 
2) La falta de RING1B provoca una acumulación de roturas a doble cadenas 
endógenas que activan una respuesta a daño a DNA mediado por ATM, que 
induce la fosforilación de P53 y la upregulación de p21/CDKN1A 
 
3) RING1B participa en la homeostasis oxidativa en cuanto, en ausencia de 
RING1B, se acumulan elevados niveles de Especie Reactiva del Oxigeno que 
dañan al ADN y activan una respuesta de daño a ADN. 
 
4) El papel de RING1B en el balance entre autorenovacción y diferenciación es 
independiente de la proliferación y de la progresión del ciclo celular 
 
5) RING1B garantiza la estabilidad de su cofactor BMI-1 en células madre 
neurales. En los fibroblastos embrionario de ratón el efecto estabilizador 
sobre BMI-1 es independiente de su actividad E3 ligasa 
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